Climate Change, Air Quality and Human Health: Quantifying the Global Mortality Impacts of Present and Future Ozone and PM2.5 Ambient Air Pollution by Silva, Raquel
 CLIMATE CHANGE, AIR QUALITY AND HUMAN HEALTH: QUANTIFYING THE 
GLOBAL MORTALITY IMPACTS OF PRESENT AND FUTURE OZONE AND PM2.5 
AMBIENT AIR POLLUTION 
 
 
Raquel Azevedo Silva 
 
 
A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill  
in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Department of Environmental Sciences and Engineering in the  








J. Jason West 
Jacqueline MacDonald Gibson 
Bryan J. Hubbell 
Marc L. Serre 























Raquel Azevedo Silva 




Raquel Azevedo Silva: Climate change, air quality and human health: quantifying the global 
mortality impacts of present and future ozone and PM2.5 ambient air pollution 
(Under the direction of J. Jason West) 
 
Exposure to ambient air pollution is detrimental to human health. This research uses 
modeled concentrations of anthropogenic ozone and fine particulate matter (PM2.5) to quantify 
global premature mortality, considering chronic cardiopulmonary diseases and lung cancer in 
adults. For the first time in global studies, the contribution of past and future climate change to 
air pollution-related mortality is isolated using output from an ensemble of 14 chemistry climate 
models, and the present-day impact of five emission sectors (Energy, Industry, Residential & 
Commercial, Land Transportation, and Shipping & Aviation) is estimated. Present-day global 
average multi-model mortality is estimated to be 470,000 (95% CI, 140,000 to 900,000) ozone-
related premature deaths/year and 2.1 (1.3 to 3.0) million PM2.5 deaths/year. Over two-thirds of 
ozone and of PM2.5 global mortality occur in East Asia and India. Using multi-model future 
concentrations for four Representative Concentration Pathways (RCP) scenarios, and projected 
future population and baseline mortality, global PM2.5 mortality is estimated to decrease relative 
to 2000 concentrations, particularly in 2100: -1.93 million (RCP2.6), -2.39 million (RCP4.5), -
1.76 million (RCP6.0) and -1.31 (-2.04 to -0.17) million (RCP8.5) deaths/year. Ozone mortality 
increases in some scenarios/periods, particularly in RCP8.5 in 2100 (316,000 [-187,000 to 1.38 
million] deaths/year), but decreases in others. While past climate change is estimated to have 
 iv 
little effect on present-day air pollution mortality, RCP8.5 climate change in 2100 is likely to be 
strongly detrimental: 215,000 (-76,100 to 595,000) PM2.5 deaths/year and 127,000 (-193,000 to 
1.07 million) ozone deaths/year. Using new simulations with a global chemical transport model 
at fine horizontal resolution (0.67°x0.5°), present-day global mortality is estimated to be 493,000 
(122,000-989,000) ozone deaths/year and 2.2 (1.0 - 3.3) million PM2.5 deaths /year. Globally, the 
Land Transportation and Residential & Commercial sectors most impact ozone mortality (16%) 
and PM2.5 mortality (30%), respectively. However, relative sectoral impacts vary among world 
regions and within each region. Air pollution is likely the most important environmental 
exposure for global human health at present. Air quality regulations and climate change 
mitigation will reduce global air pollution-related mortality, but different policies targeting 
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CHAPTER 1 – INTRODUCTION 
 
Since the industrial revolution, anthropogenic ambient air pollution has increased 
considerably. From a global public health perspective, two air pollutants cause great concern due 
to their widespread negative impact: ground-level ozone and particulate matter with aerodynamic 
diameter less than 2.5 µm (PM2.5). Many epidemiological studies have shown an association 
between exposure to ozone and PM2.5 and cardiopulmonary morbidity and mortality. Estimates 
given by health impact assessments of air pollution depend on the choice of health end-points, air 
pollutant concentrations and concentration-response (C-R) relationships, as well as exposed 
population, and baseline mortality rates. Here, I focus on the assessment of global premature 
mortality due to long-term exposure to ozone and PM2.5, considering the increased risk for 
respiratory and cardiovascular diseases and lung cancer, in adult populations. 
 
1.1 Ambient air pollution and health 
 
In the troposphere, ozone is formed by photochemical reactions between nitrogen oxides 
(NOx) and carbon monoxide, methane, and non-methane volatile organic compounds 
(NMVOCs). Emissions of these precursors from anthropogenic sources (e.g., power plants, oil 
and gas production, and traffic) and natural sources (e.g., lightning NOx and biogenic emissions 
of isoprene and other VOCs), the intensity of sunlight, other meteorological factors, and 
topography affect ozone formation. Ozone concentrations vary in space and time, and are 
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affected by transport in the atmosphere and by removal, through reaction of ozone with nitrogen 
oxide (NO) and hydrogen oxide radicals (HOx) and through deposition processes. Usually, 
ambient ozone concentrations are higher in or downwind of large urban areas and lower in city 
centers where NOX emissions by traffic lead to scavenging of ozone by NO. Also, ozone 
concentrations in the troposphere are usually higher in the warm season (“ozone season”, April 
through September in the Northern Hemisphere) and in areas with greater solar radiation 
(Seinfeld and Pandis, 2006; Sillman, 1999). 
Exposure to ozone can cause inflammation of the airways, due to oxidative stress, and 
harm lung function. Susceptible populations such as asthmatics (especially children) and the 
elderly are particularly susceptible to these adverse effects (Babin et al., 2007; Bell et al., 2014; 
Halonen et al., 2010; Stafoggia et al., 2010). Short-term exposure to ozone has been associated 
with respiratory morbidity, such as emergency department visits and hospital admissions due to 
asthma exacerbation or other respiratory conditions (e.g. Katsouyanni et al., 2009; Stieb et al., 
2009), and mortality (Bell et al., 2004, 2005, 2014; Gryparis et al., 2004; Ito et al., 2005; Levy et 
al., 2005; Wong et al., 2010). Long-term exposure to ozone has been associated with an 
increased risk of death due to respiratory disease (Jerrett et al., 2009) and death in susceptible 
populations with chronic cardiopulmonary diseases and diabetes (Zanobetti and Schwartz, 2011). 
PM2.5 is a complex mixture of different species which may be directly emitted (primary), 
or produced in chemical reactions in the atmosphere (secondary). Primary PM2.5 components 
include organic carbon (OC), black carbon (BC), dust, sea salt, and others (metals, bioaerosols, 
etc.). Secondary PM2.5 components include sulfates, nitrates, secondary organic aerosol (SOA), 
etc. which are produced from precursor gases (sulfur dioxide, NOx, ammonia, and VOCs). 
Spatial variation of PM2.5 composition is greatly dependent on emission sources. Major 
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anthropogenic sources include combustion of fossil fuels and biomass burning, while natural 
sources include volcanoes, wildfires and biogenic emissions. PM2.5 is removed through wet and 
dry deposition. (Hinds, 1999; Seinfeld and Pandis, 2006) 
While coarse particulate matter only penetrates the upper respiratory system, PM2.5 can 
penetrate deep into the lungs (Hinds, 1999; Thurston and Lippmann, 2015). Therefore, exposure 
to ambient PM2.5 can have detrimental acute (e.g., Bell et al., 2005; Dominici et al., 2006; Shah 
et al., 2013, 2015) and chronic health effects, including premature mortality from all causes and 
due to cardiopulmonary diseases and lung cancer (Brook et al., 2010; Burnett et al., 2014; Hamra 
et al., 2014; Hoek et al., 2013; Krewski et al., 2009; Lepeule et al., 2012; Lipsett et al., 2011), 
mortality from diabetes (Brook et al., 2013), detrimental effects on pregnancy outcomes (Brauer 
et al., 2008; Stieb et al., 2015), and respiratory-related postneonatal mortality (Woodruff et al., 
2006). Current epidemiological research aims to determine whether some PM2.5 species or 
emission sources are more toxic than others (Peng et al., 2009; Chung et al. 2015; Pereira et al., 
2014; Thurston and Lippmann, 2015; Wolf et al 2015), and to ascertain the impact on human 
health of spatial and temporal variation in PM2.5 composition (Bell et al., 2007a, 2009; Fann et 
al., 2009). Additional ongoing research analyzes the effects of PM2.5 at low concentrations 
(Crouse et al., 2012, Shi et al., 2015, Wellenius et al., 2012) and the implications of 
multipollutant exposures (Dominici et al. 2010; Johns et al., 2012; Oakes et al., 2014). 
Although there is strong epidemiological evidence for the causal relationship between 
long-term exposure to ozone and PM2.5 and cause-specific mortality in adult populations, there is 
considerable research and debate regarding the C-R functions, namely the shape of the functions 
for ranges of pollutant concentrations found worldwide and whether or not there is a low-
concentration threshold below which there is no increased risk from exposure. Epidemiological 
 4 
studies report the relative risk (RR) of death attributable to changes in pollutant concentration, 
and control for confounding factors such as other environmental exposures and socio-economic 
factors. For ozone, Jerrett et al. (2009) found that a log-linear relationship between exposure to 
ozone and increased risk of respiratory mortality was the best model for C-R in a very large 
American cohort of adults aged 30 and older. This study reported a RR = 1.040 (95% Confidence 
Interval, CI: 1.013-1.067) for a 10 ppb increment in ozone concentrations (two-pollutant model 
controlling for PM2.5), considering a range of concentrations of 33.3 to 104.0 ppb for average 
daily 1-hr maximum ozone concentration during the ozone season. There is no evidence that for 
average ozone concentrations below 33.3 ppb RR becomes 1. For PM2.5, several models have 
been adopted in the last two decades, as discussed in detail by Burnett et al. (2014), but the most 
widely used RRs in global health impact assessments are those reported by Kreswki et al. (2009), 
for the same American cohort as Jerrett et al. (2009), for cardiopulmonary diseases (CPD, RR = 
1.128, 95%CI: 1.077–1.182) and lung cancer (LC, RR = 1.142, 95%CI: 1.057–1.234), 
considering a log-linear relationship. More recently, following the work of Pope et al. (2011), a 
new model was proposed by Burnett et al. (2014): the Integrated Exposure-Response (IER) 
model for premature mortality due to ischemic heart disease (IHD), cerebrovascular disease 
(stroke), chronic pulmonary obstructive disease (COPD), and lung cancer. In this model, the C-R 
function flattens off at higher PM2.5 concentrations yielding different estimates of excess 
mortality for identical changes in air pollutant concentrations in low-polluted vs. highly-polluted 
locations. Ongoing research is focusing on the shape of the PM2.5 exposure-response function 
(Shin et al., 2015), and the implications of this effect for air pollution control strategies 
worldwide are discussed by Pope et al. (2015). Specifically, reduction of air pollution may have 
a stronger effect on avoided mortality per million people in regions where pollution levels are 
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lower (e.g. Europe, North America, etc.) compared with highly-polluted areas (e.g. East Asia, 
India, etc.), while a log-linear function would show the same effect. Therefore, using the IER 
model may result in lower contributions to global avoided mortality of pollution abatement in 
highly-polluted areas than using the log-linear model. 
Different methods may be used to quantify population exposure to ambient air pollution. 
Ambient concentrations may be estimated from: a) observations from surface air quality 
monitoring sites; b) observations from remote sensing; c) output from air quality modeling; d) 
model/data fusion that combines observations with modeling output using statistical methods. 
Also, estimates of excess mortality due to air pollution may be obtained for total air pollutant 
concentrations above a counterfactual (zero or low-concentration threshold) or for anthropogenic 
air pollution (assuming a counterfactual that corresponds to natural air pollution or using output 
from modeling studies that exclude anthropogenic emissions).  
Past research to estimate the global burden of disease (GBD) due to ambient air pollution 
was first restricted to urban exposure to PM2.5 based on surface measurements (Cohen et al., 
2004). In  2010, using output from a global chemical transport model (CTM) at coarse horizontal 
resolution, and accounting for both urban and rural regions, Anenberg et al. (2010) estimated 3.7 
million deaths annually due to anthropogenic PM2.5 and 0.7 million deaths due to ozone. More 
recently, the GBD 2010 study (Lim et al., 2012) used high-resolution satellite observations and 
an extensive compilation of surface measurements of PM2.5, together with output from a global 
atmospheric model, and estimated 3.2 million premature deaths annually due to PM2.5 and 




1.2 Air quality and climate change 
 
Changes in ambient concentrations of ozone and PM2.5 since preindustrial times have 
been mainly driven by changes in anthropogenic emissions of air pollutants, but they may have 
also been affected by climate change. In fact, climate change and air quality mutually affect each 
other: pollutants in the atmosphere influence climate and climate change can have an adverse 
effect on air quality. Thus, besides several other potential detrimental impacts on human health 
climate change can contribute to ozone- and PM2.5- related premature mortality due to its effect 
on air quality (Smith et al. 2014 and references therein). 
Air quality has a major impact on climate: global warming is not only driven by carbon 
dioxide (CO2) but also by other greenhouse gases (GHGs), including ozone and its precursors, 
and PM2.5. Ozone and its precursor methane contribute to warming but PM2.5 has an overall 
cooling effect, although the magnitude of this direct effect depends on its composition (e.g. BC 
absorbs solar radiation, while sulfates scatter it), and it has an indirect effect due to aerosol-cloud 
interactions that can affect radiative forcing and weather patterns. These GHGs and air pollutants 
are co-emitted by many sources, so air pollution controls may impact emissions of GHGs and 
composition of PM2.5. Therefore, actions taken to improve air pollution control (e.g. to reduce 
adverse effects on human health), may have a beneficial or detrimental effect on climate, directly 
and through co-emitted species. (Fiore et al. 2012, 2015; von Schneidemesser et al., 2015) 
In parallel, climate change influences air quality because of its effect on atmospheric 
physics and chemistry as well as on natural emissions and energy demand (Kirtman et al. 2013 
and references therein). Among several mechanisms, climate change affects photochemical 
reaction rates, biogenic emissions, deposition, and atmospheric circulation (Fiore et al. 2012, 
2015; Jacob and Winner 2009; von Schneidemesser et al. 2015; Weaver et al. 2009; Young et al. 
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2013). Future ambient concentrations will likely be driven by changes in anthropogenic 
emissions in the near term (Kirtman et al., 2013), but climate change may have a substantial 
effect in the long term, depending on the magnitude of the change. Also, the effects of climate 
change on air quality are expected to vary at the regional level.  
A number of studies have modeled future climate change and air quality from the global 
to local scales. These studies use different scenarios of future global GHG and air pollutant 
emissions, such as the IPCC (Intergovernmental Panel on Climate Change) SRES (Special 
Report on Emission Scenarios) A1, A2, B1, B2 scenarios (Nakicenovic et al., 2000), which 
consider a range of business-as-usual emissions control technologies, Current Legislation 
Emissions and Maximum Feasible Reductions scenarios (Dentener et al., 2005), and, more 
recently, the Representative Concentration Pathways (RCPs) (Van Vuuren et al., 2011a), which 
take into account different climate policies and stringent air pollution controls, mostly projecting 
decreased emissions through the 21
st
 century (Fiore et al., 2012).  
 
1.3 Research objectives 
 
A few recent global studies used output from a global atmospheric model (Anenberg et 
al., 2010; Fang et al., 2013; Lelieveld et al., 2013; Rao et al., 2012), or global modeling output 
combined with observations (Evans et al., 2013; Lim et al., 2012), to estimate the global 
mortality burden of ambient air pollution. However, the modeled air pollutant concentrations 
used in these studies were obtained from a single global model, run at a coarse horizontal 
resolution, and these studies do not quantify the impact of different emission sectors on the 
global mortality burden. Additionally, among the few studies that have estimated the impact of 
climate change on air pollution-related mortality, only one regional study (Orru et al., 2013) and 
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one global study (Fang et al., 2013) estimated the impact of past climate change, using 
concentrations from simulations with a single model, and only one regional study of the effect of 
future climate change used concentrations from a multi-model ensemble (Post et al., 2012). 
This research aims to address these research gaps by conducting health impact 
assessments to answer the following questions: 
 What is the global burden of anthropogenic ambient air pollution on premature mortality, 
and what is the contribution of past climate change to that total? 
 What is the effect of future ambient air pollution on global premature mortality, and what 
is the potential impact of future climate change?  
 What is the contribution of different anthropogenic emissions source sectors to present-
day global premature mortality? 
The three studies here included rely on an established method for estimating excess 
mortality due to exposure to air pollution, consisting of two steps: a) Obtain and process ozone 
and PM2.5 concentrations; b) Conduct the health impact assessment, including obtaining and 
processing population and baseline mortality data, estimating premature mortality using a health 
impact function, and performing sensitivity and uncertainty analyzes. 
Ozone and PM2.5 concentrations from simulations with the Atmospheric Chemistry and 
Climate Model Intercomparison Project (ACCMIP) ensemble of 14 global chemistry climate 
models are used to quantify the impact on global premature human mortality of present-day 
(Chapter 2) and future (Chapter 3) ambient air pollution at a fine horizontal resolution for global 
studies (0.5°x0.5°). Using output from a multi-model ensemble should lead to more robust 
mortality estimates than those from a single model. Additional work (Chapter 4) involves 
performing new simulations with a global CTM to evaluate the impact of different anthropogenic 
emissions source sectors (Energy, Industry, Land Transportation, Residential & Commercial, 
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Shipping & Aviation) on present-day global ozone and PM2.5-related premature mortality. These 
simulations are done at finer horizontal resolution (0.67°x0.5°) than previous global studies, and 
allow analysis of the potential bias in mortality estimates using output from models run at coarse 
resolutions. 
The ACCMIP ensemble modeled air pollutant concentrations in preindustrial times 
(1850) and in the present day (2000), using updated inventories of historical emissions, and in 
the future (2030, 2050 and 2100) using anthropogenic and biomass burning emissions from the 
RCPs (Lamarque et al., 2013 and references therein). Since these models incorporate chemistry-
climate interactions, they are sensitive to changes in emissions and to the impacts of climate 
change on ozone and PM2.5 concentrations. The studies included in Chapters 2 and 3 also aim to 
isolate the air pollution-related mortality impact of past and future climate change, at a global 
scale, using the output from an ensemble of chemistry climate models. 
The exposed population is estimated at the same resolution as the air pollutants’ model 
output, by combining total population at a very fine horizontal resolution (approximately 1 km x 
1 km) with population per 5-year age group at the country-level. Baseline mortality rates per 5-
year age group at the country-level are also mapped to the same horizontal resolution as model 
output considering the spatial distribution of total population. Future premature mortality is 
estimated from consistent projections of population and cause-specific baseline mortality rates in 
2030, 2050 and 2100.  
Since mortality estimates are restricted to adults and to specific causes, this research 
underestimates the total impact on human health of exposure to ambient air pollution (e.g. 
morbidity effects; mortality in children and younger adults; all non-accidental mortality). 
However, known uncertainty in RR, air pollutant concentrations (spread of model results) and 
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baseline mortality rates is propagated to the results using Monte Carlo simulations. Results are 
obtained at a fine enough horizontal resolution to capture both global and regional effects, and 




CHAPTER 2 - GLOBAL PREMATURE MORTALITY DUE TO ANTHROPOGENIC 







Since the industrial revolution, human activities have significantly increased the 
concentrations of ozone and fine particulate matter (with aerodynamic diameter less than 2.5 µm, 
PM2.5) in both urban and rural regions (Schulz et al., 2006; Parrish et al., 2012). These changes 
have been driven by direct changes in air pollutant emissions, and, because climate change also 
influences air quality, a component of the changes in anthropogenic air pollution may result from 
past climate change. Climate change influences air quality through several mechanisms, 
including changes in photochemical reaction rates, biogenic emissions, deposition, and 
atmospheric circulation (Jacob and Winner, 2009; Weaver et al., 2009; Fiore et al., 2012). 
Epidemiological studies have shown that ozone and PM2.5 have significant influences on 
human health, including premature mortality. Evidence for mortality influences comes from a 
large number of daily time series studies (e.g., Bell et al., 2004; HEI, 2004). There is also 
evidence for chronic effects on mortality through several large cohort studies for PM2.5 (Hoek et 
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al., 2002; Krewski et al., 2009; Lepeule et al., 2012), while evidence for chronic effects of ozone 
derives mainly from one study (Jerrett et al., 2009). 
Past research to estimate the global burden of disease due to outdoor air pollution has 
used a variety of methods. Cohen et al. (2004) estimated 800,000 premature deaths annually 
attributed to urban PM2.5 globally, based on surface measurements. Accounting for both urban 
and rural regions globally, Anenberg et al. (2010) used output from a global atmospheric model 
to estimate 3.7 ± 1.0 million deaths annually due to anthropogenic (present-day relative to 
preindustrial) changes in PM2.5 and 0.7 ± 0.3 million due to ozone. Brauer et al. (2012) used 
high-resolution satellite observations of PM2.5 together with a global atmospheric model and an 
extensive compilation of surface measurements to better represent global air pollution exposure. 
These exposure estimates were then used to estimate 3.2 ± 0.4 million premature deaths due to 
PM2.5 and 150,000 (50,000 to 270,000) due to ozone (Lim et al., 2012). 
Few studies have assessed the effects of climate change on human health via changes in 
air quality. Of those, the focus has been on the influence of future climate change, including 
assessments on a metropolitan scale (Knowlton et al., 2004; Sheffield et al., 2011), in the US 
(Bell et al., 2007b; Tagaris et al., 2009; Post et al., 2012), and globally (West et al., 2007; Selin 
et al., 2009). Of these studies, only Post et al. (2012) use a multi-model ensemble, showing 
significant variability in estimates of ozone-related mortality attributed to climate change 
depending on the atmospheric model results used. For the effects of past climate change on air 
quality and human health, Orru et al. (2013) evaluated regional effects of ozone in Europe for 
both the recent past and the future. Fang et al. (2013) conducted a global analysis of past climate 
change based on simulations from a single atmospheric model (GFDL-AM3); those model 
simulations are included in the multi-model ensemble used here. 
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Here we assess the burden of global anthropogenic air pollution on premature human 
mortality, and the contribution of past changes in climate to the total burden, using simulations 
from an ensemble of global coupled chemistry–climate models (Lamarque et al., 2013). Our 
approach to estimate the global burden of air pollution on mortality expands on that of Anenberg 
et al. (2010) by using an ensemble of model estimates of both present-day and preindustrial air 
pollution. We then use simulations that combine present-day emissions and preindustrial climate 




2.2.1. Modeled ozone and PM2.5 surface concentrations 
 
The ensemble of global model simulations was conducted under the Atmospheric 
Chemistry and Climate Model Intercomparison Project (ACCMIP) (Lamarque et al., 2013; Fiore 
et al., 2012; Stevenson et al., 2013), including 14 models, 10 of which fully couple 
meteorological and chemical processes. Here we only analyze historical ACCMIP simulations, 
and not future simulations under different emissions scenarios. All models in ACCMIP used 
nearly identical anthropogenic emissions for both the present-day (2000) and preindustrial 
(1850), but differ in natural emissions (Lamarque et al. 2010, 2013; Young et al., 2013). 
Comparison with observations suggests that the models reproduce aerosol optical depth well, 
though with a tendency to underestimate particularly in East Asia (Shindell et al., 2013a). For 
ozone, the models also agree well with satellite and ozonesonde observations, but with a 
tendency to overestimate in the Northern Hemisphere and underestimate in the Southern 
Hemisphere (Young et al., 2013). Differences in natural emissions (biogenic VOCs), model 
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chemical mechanisms, and ozone transport from the stratosphere contribute to the spread of 
ozone concentrations across models (Young et al., 2013). 
For ozone, we use output from 14 models that report results from both 1850 and 2000 
simulations; of these, 9 models also report results from an experiment where 2000 emissions are 
used together with 1850 climate (‘Em2000Cl1850’), to separate the influence of past climate 
change on air quality. For PM2.5, 6 models report results from 1850 and 2000, and 5 of these also 
report results for Em2000Cl1850. 
We refer to the absolute difference in concentrations between 1850 and 2000 as 
‘anthropogenic’ air pollution, although 1850 includes some anthropogenic emissions, such as 
from biomass burning (Lamarque et al., 2010), and the simulated past climate change includes 
some natural forcings as well as anthropogenic forcings. In attributing air pollution changes to 
past climate change, this approach accounts for effects of climate change on atmospheric 
processes and natural emissions, but ignores effects on anthropogenic emissions. To reduce the 
effects of inter-annual variability, models typically report several years of output for each 
simulation; we use the average of all years reported by most models (varying between 1 and 10 
years), and use 10 years for models that reported more than 10 years. In all cases, modeled 
concentrations from the lowest vertical coordinate are taken to represent surface concentrations. 
Modeled concentrations are processed by calculating metrics consistent with the 
underlying epidemiological studies we use to estimate premature mortality. For PM2.5, this is the 
simple annual average concentration (Krewski et al., 2009). For ozone, this is the 6-month ozone 
season average of the 1-h daily maximum ozone concentration (Jerrett et al., 2009); we estimate 
the ozone season in each grid cell as the consecutive 6-month period with highest average 1-h 
daily maximum ozone. Model results for these two metrics are then regridded from each model’s 
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native grid resolution (varying from 1.9°x 1.2° to 5°x5°) to a common 0.5°x0.5° resolution used 
to estimate mortality. For ozone, 5 of the 14 models report only monthly average ozone 
concentrations; we calculate the average ratio of the 6-month 1-h maximum ozone to the annual 
average for the remaining 9 models and apply this ratio to these 5 models. For PM2.5, 6 models 
report results for PM2.5 species, and 4 of these models also report a PM2.5 metric, estimated by 
each model as a sum of species using a formula unique to that model. For all 6 models, we 
estimate total PM2.5 as a sum of species using a common formula (see supporting information, 
Appendix A), and as a sensitivity analysis, we estimate mortality using the PM2.5 reported by 4 
models.  
For the burden of disease results, mortality is estimated for each model based on the 
change in concentration between the 2000 and 1850 simulations. This approach models 
anthropogenic air pollution as a result of both anthropogenic air pollutant emissions and past 
climate change, in contrast to Anenberg et al. (2010) who did not include past climate change. 
For mortality due to past climate change, we use the change in concentration between the 2000 
and Em2000Cl1850 simulations. 
 
2.2.2 Health impact assessment 
 
Mortality due to long-term exposure to air pollution is estimated following the methods 
of Anenberg et al. (2010), with updated input data. Like Anenberg et al. (2010), we estimate 
anthropogenic air pollution as a modeled change in concentration between the present-day and 
preindustrial, rather than evaluating mortality relative to a counterfactual low concentration 
(normally a single value representing unpolluted conditions or below which changes in 
concentration are assumed not to affect mortality, e.g., Cohen et al., 2004). We use 
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epidemiological concentration–response functions (CRFs, see supporting information, Appendix 
A) for chronic mortality from the American Cancer Society (ACS) study for PM2.5 
cardiopulmonary disease (CPD) and lung cancer (LC) mortality (Krewski et al., 2009), and for 
ozone respiratory mortality (Jerrett et al., 2009). We select CRFs from the ACS study because 
this cohort includes the largest population of the available long-term PM2.5 studies (Hoek et al., 
2002; Lepeule et al., 2012), and it is the only study that reports long-term ozone mortality (Jerrett 
et al., 2009). By analyzing PM2.5 and ozone mortality based on the same study, we achieve 
greater consistency and reduce the potential for double-counting of mortality from both 
pollutants. Relative risks from the ACS study differ from other cohort studies because of 
differences in population characteristics, pollutant concentrations, and epidemiological methods. 
CRFs from the US are applied globally, as available studies of the effects of ozone and PM2.5 on 
mortality outside of the US are broadly consistent (Hoek et al., 2002; HEI 2004, 2010), and 
CRFs are not strongly dependent on sex, age, or race (Krewski et al., 2009; Jerrett et al., 2009). 
Nonetheless, differences in population exposure (including pollutant concentrations, the 
composition of PM2.5 and air pollutant mixtures, and activity patterns) and susceptibility 
(including underlying health status) may cause differences in responses to air pollution 
internationally. 
No low-concentration thresholds are assumed, as there is no clear evidence for the 
presence of thresholds. We analyze the sensitivity of the results to low-concentration thresholds 
of 33.3 ppb for ozone and 5.8 µg m
-3
 for PM2.5, below which changes in concentration are 
assumed to have no effect, as these are the lowest measured levels in ACS. 
Consistent with ACS, we limit our analysis to adults aged 30 and older (see Table A.10 
and Figure A.6). Population data comes from LandScan (Dobson et al., 2000) for the year 2008 
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at approximately 1 km
2
 resolution, which is then regridded to 0.5°x0.5°. The fraction of the 
population aged 30 and older in the year 2008 is taken from UN statistics for individual 
countries. Note that present-day population is used in all cases, so that we evaluate the effect of 
2000 air pollution relative to 1850 or relative to the Em2000Cl1850 simulations, for present-day 
mortality. Baseline mortality rates (also for 30 and older) are from the WHO for individual 
countries, using the most recent data available for each country between 2000 and 2008, and 
when unavailable, reported regional rates are used (see supporting information).Baseline 
mortality rates for individual countries were gridded to the 0.5°grid using ArcGIS10 
geoprocessing tools. 
 
2.3. Global mortality burden of anthropogenic air pollution 
 
Figures 2.1 and 2.2 show estimates of premature mortality due to anthropogenic ozone 
and PM2.5 for each model, and changes in concentration underlying these estimates are presented 
in the supporting information (Appendix A). The average estimate across the 14 models suggests 
that 470,000 premature respiratory deaths occur globally and annually due to anthropogenic 
increases in ozone, with no low-concentration threshold. Accounting for both the 95% 
confidence interval (CI) on the CRF, reported by Jerrett et al. (2009), and the distribution of 
results from the 14 models, using Monte Carlo sampling, yields a 95% CI of 140,000 to 900,000 
(uncertainty ranges reported hereafter follow the same methods). Global ozone mortality is about 
20% lower when a low-concentration threshold is used. In Figure 2.3 and Table 2.1, ozone-
related mortality is widespread globally, as ozone has increased essentially everywhere from 
human activities, but is greatest in highly populated and highly polluted areas of India and East 
Asia, which account for 68% of the global total.  
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For PM2.5 estimated as a sum of species, the 6-model average indicates that 2.1 (1.3 to 
3.0) million premature CPD and LC deaths occur globally and annually due to anthropogenic 
increases, with no low-concentration threshold. Of these deaths, 93% are related to CPD and 7% 
to LC. Relative to ozone, there is less scatter among the models, with a coefficient of variation 
(σ/µ) among models of 0.10 for PM2.5, compared to 0.26 for ozone. For both PM2.5 and ozone, 
the uncertainty in the CRF is greater than the uncertainty over the range of models. Global PM2.5 
mortality is 11% lower for the multi-model average when using a low-concentration threshold of 
5.8 µg m
-3
, and is 19% lower when using PM2.5 as reported by 4 models. While the formulas for 
estimating PM2.5 differ between models, the larger change in concentrations when adding species 
is mainly due to the omission of nitrate in the PM2.5 reported by the models. Large differences 
may also result from differences in how dust and sea salt are added to PM2.5, as models that 
calculate PM2.5 use size-resolved information and so are likely more accurate than the common 
formula used here. PM2.5-related mortality is widespread in populated regions, principally in East 
Asia and India, but also in Southeast Asia, Europe, and the Former Soviet Union. However, 
some locations are modeled as having a decrease in PM2.5 relative to 1850, including the 
southeast US and parts of Latin America, and small regions elsewhere. In the southeast US, this 
decrease is caused by reductions in biomass burning relative to 1850, as changes in primary 
organic carbon are primarily responsible for the decrease, which also is apparent in the radiative 
forcing due to biomass burning aerosols (Shindell et al., 2013a). Local decreases in India and 
Africa likely relate to past climate change (see supporting information, Appendix A). 
These estimates of the global burden are smaller than those reported by Anenberg et al. 
(2010). Since Anenberg et al. (2010) used the same CRFs and only small differences in global 
population and baseline mortality rates, the lesser estimated mortality is mainly due to 
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differences in modeled concentrations. While the model used in that study differs from the 
ensemble used here, the greater difference is likely to be the different emissions used for both the 
present-day and preindustrial simulations (Lamarque et al., 2010; Fang et al., 2013).  
These global burden estimates are also greater for ozone but less for PM2.5 than were 
estimated in the most recent Global Burden of Disease study (Lim et al., 2012). For ozone, these 
differences are likely explained by the fact that modeled 1850 ozone (Table A.5) is lower than 
the assumed counterfactual low concentration of Lim et al. (2012) of 37.6 ppb. For PM2.5, the 
modeled 1850 concentrations are close to the counterfactual concentrations used by Lim et al. 
(2012) of 7:3 µg m
-3
; the smaller estimate here may be due to differences in CRFs. 
Our estimates using results from the GFDL-AM3 simulations of Fang et al. (2013) are 
45% higher for ozone mortality and 24% higher for PM2.5 mortality than those reported by Fang 
et al. (2013); this difference is accounted for mainly by the smaller global population aged 30 
years and older for the year 2000 used in that study and, to a lesser extent, differences in baseline 
mortality rates. 
 
2.4. Air pollution mortality attributed to past climate change 
 
The 9-model average estimate of the effect of past climate change on ozone respiratory 
mortality is 1,500 (-20,000 to 27,000) deaths annually with no threshold (Figure 2.4). There is 
large variability among models, with six of nine models suggesting that past climate change 
caused ozone mortality to increase. In Figure 2.5 and Table 2.2, deaths are greatest in East Asia 
for the multi-model average, but also positive in North America and parts of India. In Figure 2.6, 
most models predict ozone decreases due to climate change in tropical regions and over oceans. 
This likely results from increases in water vapor, which causes greater production of HOx 
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radicals and greater destruction of ozone. Over polluted regions, however, ozone increases from 
faster reaction rates and meteorological changes (Jacob and Winner 2009). Because most models 
reported several years of simulations, the variability between models is not likely a result of 
inter-annual meteorological variability. 
For PM2.5, the 5-model average mortality (CPD + LC) attributed to past climate change is 
2,200 (-350,000 to 140,000) deaths annually, with no threshold and estimating PM2.5 as a sum of 
species (Figure 2.7). Four of the five models estimate an increase in deaths, but the average is 
decreased by one model (HadGEM2) that estimates -283,000 deaths from PM2.5 decreases due to 
climate change. The multi-model median mortality is 61,000 deaths annually, and, if HadGEM2 
is excluded, the multi-model average is 74,000 (30,000 to 140,000) deaths yr
-1
. Average 
mortality is higher when using PM2.5 from the four models that reported it, and without the large 
negative uncertainty, as HadGEM2 did not report PM2.5. In Figure 2.5 and Table 2.2, the 5-
model average shows that past climate change caused the largest increases in PM2.5 premature 
mortality in East Asia, and notable increases elsewhere including North America, but decreases 
in India and parts of Africa, the Former Soviet Union and Europe. The strong negative mortality 
estimate from HadGEM2 is the result of PM2.5 decreases over India, driven by changes in dust, 
as India has a large exposed population. Figure 2.6 shows that most models predict an increase in 
PM2.5 over India due to climate change, with only HadGEM2 being a strong exception. Most 
models predict increases in PM2.5 over land, but it is difficult to explain the different regional 
patterns of concentration changes due to past climate change across the different models. These 
inter-model differences for both ozone and PM2.5 are likely driven by the processes included in 
the different models, such as whether and how emissions from dust, vegetation, and lightning are 
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modified as a result of climate change, and differences in how the models represent past climate 




We estimate that in the present day, anthropogenic changes to air pollutant concentrations 
since the preindustrial are associated annually with 470,000 (95% CI, 140,000 to 900,000) 
premature respiratory deaths related to ozone, and 2.1 (1.3 to 3.0) million CPD and LC deaths 
related to PM2.5. Our estimates differ from those of Lim et al. (2012) in that we estimate 
mortality for changes in air pollution relative to the modeled preindustrial conditions, rather than 
using a counterfactual low concentration. Relative to Anenberg et al. (2010), our results also 
differ mainly because of the different emissions used in the models for preindustrial and present-
day conditions, and by using modeled concentrations from an ensemble of models rather than a 
single model. 
There is significant variability in mortality estimates driven by different atmospheric 
models, even though these models used very similar anthropogenic emissions, highlighting the 
uncertainty in basing results on a single model. Variability among models is higher for ozone 
than for PM2.5, but for both pollutants, it contributes less to overall uncertainty than the 
uncertainty in CRFs. The uncertainty in CRFs is understated because it does not account for the 
full range over the literature—e.g., use of the CRF for PM2.5 from Lepeule et al. (2012) would 
lead to higher mortality estimates. The relative magnitude of results using different CRFs and 
with low-concentration thresholds, analyzed by Anenberg et al. (2010), would also apply here. 
As for previous studies that estimate the mortality burden of outdoor air pollution, our methods 
likely underestimate the true burden because we have limited the evaluation to adults aged 30 
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and older, and base the analysis on coarse-resolution models that likely underestimate exposure, 
particularly for PM2.5 in urban areas (Punger and West, 2013). On the other hand, recent studies 
suggest that the relationship between PM2.5 and mortality may flatten at high concentrations 
(Pope et al., 2011), suggesting that we may overestimate PM2.5 mortality in regions with very 
high concentrations. We also caution that there are large uncertainties in applying CRFs from the 
US globally. 
Air pollution-related mortality due to past climate change is shown to be significantly 
smaller than the total anthropogenic burden—i.e., anthropogenic increases in emissions likely 
have had a much greater influence on air pollutant concentrations than past climate change. We 
estimate here that 1,500 (-20,000 to 27,000) premature respiratory deaths related to ozone and 
2,200 (-350,000 to 140,000) CPD and LC deaths related to PM2.5 occur each year due to past 
climate change. The large uncertainties reflect significant variability among different 
atmospheric models, with some models estimating an overall decrease in mortality from past 
climate change. The multi-model averages for both ozone and PM2.5 mortality are very small by 
coincidence, as the results for individual models show a large range of positive and negative 
values. Consequently, it cannot be clearly concluded that past climate change has increased air 
pollution mortality. This large variability among models suggests that using a single model to 
represent past climate change may have significant uncertainties. This conclusion agrees with 
that of Post et al. (2012) who analyzed the effects of future climate change on air pollution 
mortality in the US from an ensemble of atmospheric models. As models continue to develop 
and more comprehensively represent the mechanisms by which climate change might influence 
air quality, we should expect that large differences between estimates based on different models 
will likely persist. 
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2.6. Tables and Figures 
 
Table 2.1 – Regional premature annual deaths from anthropogenic outdoor air pollution (2000 – 
1850), for ozone (respiratory) and PM2.5 calculated as a sum of species (CPD + LC), shown for 
the mean and full range across 14 models for ozone and 6 models for PM2.5 (3 significant figures 
shown).  Also shown are deaths per million people (present-day exposed population aged 30 and 
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Table 2.2 – Regional premature annual deaths attributable to past climate change (2000 – 
Em2000Cl1850), for ozone (respiratory) and PM2.5 calculated as a sum of species (CPD + LC), 
shown for the mean and full range across 9 models for ozone and 5 models for PM2.5 (3 
significant figures shown).  Also shown are deaths per million people (present-day exposed 























































































































































Figure 2.1 – Estimates of the current global burden of anthropogenic ozone (2000-1850) on 
respiratory mortality from 14 models and the multi-model average, without and with a low-
concentration threshold (33.3 ppb).  Uncertainty for individual models reflects only the 95% 
confidence intervals on the CRF (Jerrett et al. 2009).  Uncertainty for the multi-model average is 
a 95% CI including uncertainty in the CRF and across models.  See Supplemental Material 


























Figure 2.2 – Estimates of the current global burden of anthropogenic PM2.5 (2000-1850) on CPD 
and LC mortality with no low concentration threshold, for PM2.5 calculated as a sum of species 
for 6 models (dark blue), and for PM2.5 as reported by 4 models (dark green).  The corresponding 
estimates with a low-concentration threshold (5.8 µg m
-3
) are shown for PM2.5 calculated as a 
sum of species (light blue), and for reported PM2.5 (light green).  Uncertainty for individual 
models reflects only the 95% confidence intervals on the CRF (Krewski et al. 2009). Uncertainty 














, for the multi-model mean in each grid cell, for (top) ozone (respiratory 
mortality) for 14 models and (bottom) PM2.5 (CPD + LC) for the sum of species for 6 models.   
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Figure 2.4 – Estimates of the current global ozone respiratory mortality attributed to past climate 
change (2000–Em2000Cl1850), for 9 models and the multi-model average, with and without a 
low-concentration threshold (33.3 ppb).  Uncertainty for individual models reflects only the 95% 
confidence intervals on the CRF (Jerrett et al. 2009).  Uncertainty for the multi-model average is 

































, for the multi-model mean in each grid cell, for (top) ozone (respiratory 
mortality) for 9 models and (bottom) PM2.5 (CPD + LC mortality) for the sum of species for 5 




Figure 2.6 – The number of models that show a positive change in concentration in each grid cell 
due to past climate change (2000–Em2000Cl1850), for (top) the 6-month ozone season average 
of 1-hr. daily maximum ozone (of 9 models total), and (bottom) annual average PM2.5 calculated 
as a sum of species (5 models).   
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Figure 2.7 – Estimates of the global PM2.5 CPD and LC mortality attributed to past climate 
change (2000–Em2000Cl1850), for PM2.5 calculated as a sum of species for 5 models (dark 
blue), and for PM2.5 as reported by 4 models (dark green).  Light-colored bars show the 
corresponding estimates with a low-concentration threshold (5.8 µg m
-3
).  Uncertainty for 
individual models reflects only the 95% confidence intervals on the CRF (Krewski et al. 2009).  
Uncertainty for the multi-model average is a 95% CI including uncertainty in the CRF and across 





CHAPTER 3 - THE EFFECT OF FUTURE AMBIENT AIR POLLUTION ON HUMAN 






Ambient air pollution has adverse effects on human health, including premature 
mortality. Exposure to ground-level ozone is associated with respiratory mortality (e.g. Bell et 
al., 2005; Gryparis et al., 2004; Jerrett et al., 2009; Levy et al., 2005). Exposure to fine 
particulate matter (PM2.5) causes mortality due to cardiopulmonary diseases and lung cancer (e.g. 
Brook et al., 2010; Burnett et al., 2014; Hamra et al., 2014; Krewski et al., 2009; Lepeule et al., 
2012). 
Future ambient air quality will be influenced by changes in emissions of air pollutants 
and by climate change. Changes in anthropogenic emissions will likely dominate in the near-
term (Kirtman et al., 2013 and references therein), and these changes depend on several socio-
economic factors including economic growth, energy demand, demographic trends and land use 
change, as well as air quality and climate policies. Climate change will affect the ventilation and 
dilution of air pollutants, photochemical reaction rates, removal processes, and 
stratosphere−troposphere exchange of ozone (Fiore et al., 2012, 2015; Jacob and Winner, 2009; 
von Schneidemesser et al., 2015; Weaver et al., 2009). Natural emissions may also be 
significantly affected by climate change: biogenic emissions and nitrogen oxides (NOx) 
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emissions from lightning are expected to increase in a warmer climate, although biogenic 
emissions will also depend on CO2 concentrations and the amount and type of vegetation (Young 
et al., 2013). Ozone is likely to increase in polluted regions during the warm season, particularly 
in urban areas and during pollution episodes. In remote regions, however, ozone is likely to 
decrease due to greater water vapor concentrations, which increase production of hydrogen oxide 
radicals that destroy ozone. The effects of climate change on PM2.5 concentrations are uncertain 
and vary regionally due to different changes in precipitation, wildfires and biogenic emissions, 
and different PM2.5 composition and other factors (Fiore et al., 2012, 2015; Jacob and Winner, 
2009; von Schneidemesser et al., 2015; Weaver et al., 2009). 
The Atmospheric Chemistry and Climate Model Intercomparison Project (ACCMIP) 
simulated preindustrial (1850), present-day (2000) and future (2030, 2050 and 2100)  
concentrations of ozone and PM2.5 with an ensemble of 14 state-of-the-art chemistry climate 
models (Table B.1) to support the IPCC’s Fifth Assessment Report (Lamarque et al., 2013, 
Stevenson et al., 2013). Using modeled 1850 and 2000 concentrations from this ensemble, we 
showed previously that exposure to present-day anthropogenic ambient air pollution is associated 
with 470,000 (95% confidence interval, 140,000 to 900,000) deaths/year from ozone-related 
respiratory diseases, and 2.1 (1.3 to 3.0) million deaths/year from PM2.5-related cardiopulmonary 
diseases and lung cancer (Silva et al., 2013). The contribution of past climate change to this 
anthropogenic total is much smaller than that of anthropogenic increases in emissions, with some 
models suggesting a decrease in mortality associated with past climate change (Silva et al., 
2013). The impact of future climate change on human health due to its effect on air quality has 
been the focus of previous research at a metropolitan scale (Knowlton et al., 2004; Sheffield et 
al., 2011), in the US (Bell et al., 2007; Fann et al., 2015; Post et al., 2012; Tagaris et al., 2009), 
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in Europe (Orru et al., 2013), and globally (Fang et al., 2013; Selin et al., 2009; West et al., 2007, 
2013), but only one study, conducted at a regional scale, used an ensemble of models (Post et al., 
2012). A recent multi-scale study (Likhvar et al., 2015) considered two emissions scenarios of 
climate and regional air quality policies to estimate future ozone and PM2.5-related mortality 
globally, in Europe and in Ile-de-France, but the effect of climate change on air quality was not 
isolated. 
The ACCMIP model ensemble simulated future air quality through 2100 considering four 
global greenhouse gas (GHG) and air pollutant emissions scenarios projected in the 
Representative Concentration Pathways (RCPs) (Van Vuuren et al., 2011a and references 
therein). The four RCPs were developed by different research groups with different assumptions 
regarding the pathways of population growth, economic and technological development, and air 
quality and climate policies. Anthropogenic radiative forcing in 2100 ranges from a very low 
level in the mitigation scenario RCP2.6 (Van Vuuren et al., 2011b), to medium levels in the two 
stabilization scenarios, RCP4.5 (Thomson et al., 2011) and RCP 6.0 (Masui et al., 2011), to a 
high level in the very high baseline emissions scenario RCP8.5 (Riahi et al., 2011).  All RCPs 
assume increasingly stringent air pollution controls as countries develop economically, leading to 
decreases in air pollutant emissions that reflect the different methods of the different groups 
(e.g., Smith et al., 2011). While most air pollutants are projected to decrease, ammonia increases 
due the projected increase in population and food demand, and methane increases in RCP8.5 
because of high fossil fuel use for energy production. However, these scenarios follow different 
pathways in different regions. In some regions, emissions increase to mid-century before 
decreasing, while in other regions emissions are already decreasing. Models in the ACCMIP 
ensemble incorporate chemistry-climate interactions, including mechanisms by which climate 
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change affects ozone and PM2.5, although models do not all include the same mechanisms of 
interactions, and do not always agree on the net effect of these interactions (von Schneidemesser 
et al., 2015).  
Using modeled ozone and PM2.5 concentrations from the ACCMIP ensemble, we 
estimate the future premature human mortality associated with exposure to ambient air pollution, 
and the contribution of climate change to overall mortality (due to emissions and climate 
change). Our premature mortality estimates are obtained using a health impact function, 
combining the relative risk of exposure to changes in air pollution with future exposed 
population and cause-specific baseline mortality rates. We estimate overall future premature 
mortality considering the difference in air pollution associated with 2030, 2050 and 2100 
emissions and climate relative to that resulting from 2000 emissions and climate. We isolate the 
effect of climate change on air quality through ACCMIP simulations where 2000 emissions were 
used together with future year climate. Results are obtained at a fine enough horizontal 
resolution to capture both global and regional effects, and may inform regional and national air 




3.2.1 Ambient ozone and PM2.5 concentrations 
 
Ozone and PM2.5 concentrations for the present day (2000) and for 2030, 2050 and 2100 
for the four RCPs are calculated using the output of simulations by the ACCMIP ensemble of 
chemistry climate models. As described by Lamarque et al. (2013) not all models are truly 
coupled chemistry climate models. OsloCTM2 and MOCAGE are chemical transport models 
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driven by external meteorological fields, and UM-CAM and STOC-HadAM3 do not model the 
feedback of chemistry on climate.  
All ACCMIP models used nearly identical anthropogenic and biomass burning emissions 
for the present day and future, but they used different natural emissions (e.g. biogenic volatile 
organic compounds, ocean emissions, soil and lightning NOx), which mostly impacted ozone 
precursor concentrations (Lamarque et al., 2013; Young et al., 2013). Model output shows good 
agreement with observations, both for ozone (Young et al., 2013) and for PM2.5 (Shindell et al., 
2013), although models tend to  overestimate ozone in the Northern Hemisphere and 
underestimate it in the Southern Hemisphere, and to underestimate PM2.5, particularly in East 
Asia. Future concentrations of air pollutants vary across scenarios and models, but ozone is 
projected to decrease except in RCP8.5, likely associated with the increase in methane 
concentrations specific to this scenario and to the effect of climate change (von Schneidemesser 
et al., 2015; Young et al., 2013). 
We obtained hourly and monthly output from the ACCMIP ensemble simulations for a 
base year (2000) and future projections under the four RCPs (2030, 2050 and 2100), with each 
time period corresponding to simulations of up to 10 years, depending on the model. Only two 
models reported results for all four RCP scenarios and three future years – GFDL-AM3 and 
GISS-E2-R.  PM2.5 is calculated as a sum of species reported by six models (see Supplemental 
Material, Appendix B), and four of these models reported their own estimate of PM2.5 (Table 
B.1). Our PM2.5 formula includes nitrate, which was reported by three models, and we treat this 
species differently for the calculation of future mortality versus isolating the effect of climate 
change. In the former case, we add the average nitrate concentrations in each cell reported by the 
other models; in the latter case we omit nitrate from our PM2.5 formula to avoid imposing 
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changes inconsistent with the effect of climate change, as done by Silva et al. (2013).  We use 
our PM2.5 estimates to obtain all mortality results, and we perform a sensitivity analysis using the 
PM2.5 concentrations reported by four models using their own PM2.5 formulas, which differed 
among models.  The native grid resolutions of the 14 models varied from 1.9°x1.2° to 5°x5°; we 
regrid ozone and PM2.5 species surface concentrations from each model to a common 0.5°x0.5° 
horizontal resolution. 
Ozone and PM2.5 concentrations are calculated in each grid cell for each model 
separately. For both pollutants, we use identical metrics to those reported in the epidemiological 
studies we considered for the health impact assessment (next section): 
 Seasonal average of daily 1-hr maximum ozone concentration, for the six consecutive 
months with highest concentrations in each grid cell; 
 Annual average PM2.5 concentration. 
Among the 14 models, five models reported only monthly ozone concentrations, while 
the remaining models reported both hourly and monthly values.  We calculate the ratio of the 
seasonal average of daily 1-hr maximum to the annual average of monthly concentrations, for 
each scenario/year, for those that reported both hourly and monthly concentrations. Then we 
apply that ratio to the annual average of monthly ozone concentrations for the former five 
models, as previously done by Silva et al. (2013). The differences in ozone and PM2.5 
concentrations between future year (2030, 2050 and 2100) and 2000 are shown in Tables B.2 and 
B.3, for each model. For ten world regions (Figure B.1), we also estimate regional multi-model 
averages for each scenario/year (Figures B.2 and B.3). 
We isolate the effect of climate change on air quality as the difference in concentrations 
between ACCMIP simulations where 2000 emissions were used together with future year 
climate, using RCP8.5 sea surface temperatures and GHGs for 2030 and 2100 (referred to as 
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“Em2000Cl2030” and “Em2000Cl2100”), and simulations with 2000 emissions and climate 
(“acchist2000”) (Lamarque et al. 2013) (Tables B.4 and B.5, Figures B.4 and B.5). We quantify 
the proportion of the effect of climate change in overall change in future mortality due to 
emissions and climate change, by dividing premature mortality using these simulations with 
premature mortality for RCP8.5 minus acchist2000.  
 
3.2.2 Health impact assessment 
 
We estimate future air pollution-related cause-specific premature mortality using similar 
methods to Silva et al. (2013), except for our use of the recently published Integrated Exposure-
Response (IER) model for PM2.5 (Burnett et al., 2014) and projections of population and baseline 
mortality rates from the International Futures (IFs) integrated modeling system (Hughes et al., 
2011). 
We apply the following health impact function to estimate premature mortality associated 
with exposure to ozone and PM2.5 ambient air pollution (∆Mort) in each grid cell: ∆Mort = y0 * 
AF *Pop, where y0 is the baseline mortality rate (for the exposed population), AF = 1 – 1/RR is 
the attributable fraction (RR = relative risk of death attributable to change in pollutant 
concentration from future year relative to 2000), and Pop is the exposed population (adults aged 
25 and older). We estimate the change in pollutant concentrations due to future emissions and 
climate by calculating the difference between concentrations in each future year (2030, 2050 and 
2100) and in 2000. This approach differs from a calculation of the global burden of air pollution-
related mortality since we use 2000 concentrations as baseline. In our previous study (Silva et al., 
2013) we estimated the present-day global burden, using concentrations in 1850 as baseline. 
Here we estimate mortality due to future concentrations, relative to the present, to avoid applying 
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the health impact function at very low concentrations where there is less confidence in the 
exposure-response relationship.  For example, the simulated 1850 concentrations are often below 
the lowest measured value of the American Cancer Society study (Jerrett et al., 2009; Krewski et 
al., 2009). This approach allows us to compare results with those of prior studies of the effect of 
climate change on air quality and health, which also use the present day as baseline. For 
illustration, we also estimate mortality relative to 1850 concentrations, which could be regarded 
as global burden of disease calculations, following Silva et al. (2013). 
For each model, we estimate ozone-related mortality due to chronic respiratory diseases 
(RESP, ICD-9 BTL: B347), using RR from Jerrett et al. (2009). We also estimate PM2.5-related 
mortality due to ischemic heart disease (IHD, ICD-9: 410-414), cerebrovascular disease 
(STROKE, ICD-9: 430-435, 437.0-437.2, 437.5-437.8), chronic obstructive pulmonary disease 
(COPD, ICD-9: 490-492.8, 494, 496) and lung cancer (LC, ICD-9 BTL: B101), using RRs from 
the IER model (Burnett et al., 2014). We apply the IER model instead of RRs from Krewski et 
al. (2009), used by Silva et al. (2013), as the newer model should better represent the risk of 
exposure to PM2.5, particularly at locations with high ambient concentrations. 
Each RCP includes its own projection of total population, but not population health 
characteristics. For all scenarios, we choose to use a common projection of population and 
baseline mortality rates per age group from the IFs (Figures B.6 and B.7). IFs projects population 
and mortality based on UN and WHO projections from 2010 through 2100, per age group and 
country, mostly based on three drivers – income, education, and technology (Hughes et al., 
2011). Population projections from IFs differ from those underlying each RCP, but lie within the 
range of the latter (Figure B.6). IFs project rising baseline mortality rates for cardiovascular 
diseases (CVD) and RESP, globally and in most regions, particularly in East Asia and India, 
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reflecting an aging population. By using projections from IFs, we have a single source of 
population and baseline mortality rates, assuring their consistency and enabling us to isolate the 
effect of changes in air pollutants concentrations across the RCPs. Had we used the population 
projections from each scenario, the magnitude of the changes (increases or decreases in 
premature mortality relative to 2000) would likely increase in RCP8.5, but decrease in RCP2.6, 
RCP4.5 and RCP6.0. With the exception of Europe, FSU and East Asia, where population is 
projected to decrease in 2100 relative to 2000, had we used present-day population and baseline 
mortality we would have obtained lower estimates for excess or avoided mortality in each 
scenario/year, as projected increases in population and baseline mortality magnify the impact of 
changes in air pollutant concentrations. Therefore, we estimate the overall effect of future air 
pollution and we isolate the effect of climate change considering the population that will 
potentially be exposed to those effects. We also obtain different estimates of changes in future 
mortality than if we had calculated the global burden in each year, using population and baseline 
mortality rates in that year, and subtracted the present-day burden. Our results do not reflect the 
potential synergistic effect of a warmer climate on air pollution-related mortality (Wilson et al., 
2014 and references therein) and thus may underestimate the effect of future climate change. A 
few studies have analyzed possible effect modification and interactions between temperature and 
air pollution and found increased ozone (Jhun et al., 2014; Pascal et al., 2012; Ren et al., 2008a, 
2009; Wilson et al., 2014) and particulate matter-related mortality (Roberts 2004) at high 
temperatures. Also, temperature-related mortality has been found to increase at high levels of 
ozone and particulate matter (e.g. Breitner et al. 2014; Burkart et al. 2013; Ren et al., 2006, 
2008b). 
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Country-level population projections for 2030, 2050 and 2100 are gridded to 0.5°x0.5° 
using ArcGIS 10.2, assuming that the spatial distributions of total population within each country 
is unchanged from the 2011 LandScan Global Population Dataset at approximately 1 km 
resolution (Bright et al., 2012), and that the exposed population is distributed identically as the 
total population within each country. IFs projections of mortality rates for CVD are used to 
estimate baseline mortality rates for IHD and STROKE considering their present-day proportion 
in CVD (using GBD 2010 baseline mortality rates), as are RESP projections for COPD and 
malignant neoplasms for LC. We estimate the number of deaths per 5-year age group per country 
using the country level population and gridded using ArcGIS 10.2. The resulting population and 
baseline mortality per age group at 30"x30" are regridded to 0.5°x0.5° matching the 
concentrations of air pollutants. 
Uncertainty from the RRs is propagated separately for each model-scenario-year to 
mortality estimates in each grid cell, through 1000 Monte Carlo simulations. For ozone, we use 
the reported 95% Confidence Intervals (CIs) for RR (Jerrett et al., 2009) and assume a normal 
distribution, while for PM2.5 we use the parameter values of Burnett et al. (2014) for 1000 MC 
simulations. Uncertainty in air pollutant concentrations is based on the spread of model results, 
by calculating the average and 95% CI for the pooled results of the 1000 MC simulations for 
each model. Uncertainties associated with population and baseline mortality rates are not 








3.3.1 Future premature mortality 
 
Future changes in ozone as projected in the four RCPs will cause overall respiratory 
mortality to increase in 2030 relative to 2000 concentrations, but in 2100 it decreases for all 
scenarios but RCP8.5 (Figures 3.1, Tables B.6 and B.7). In 2030, all RCPs show increases in the 
multi-model average ozone mortality: 11,600 (RCP2.6), 99,000 (RCP4.5), 70,200 (RCP6.0) and 
264,000 (RCP8.5) deaths/year. For each RCP, however, some models show decreases in 
mortality. In 2050, we estimate decreases in ozone premature mortality for RCP2.6 (-449,000 
deaths/year) and RCP4.5 (-361,000 deaths/year) and increases for RCP6.0 (434,000 deaths/year) 
and RCP8.5 (246,000 deaths/year); these averages are obtained from only 3 or 4 models, 
depending on the scenarios, which makes it difficult to compare with the other two periods. In 
2100, global mortality increases in RCP8.5 (316,000 deaths/year) relative to 2000, but it 
decreases for the other three RCPs with all models agreeing in sign of the change: -1.02 million 
(RCP2.6), -913,000 (RCP4.5) and -715,000 (RCP6.0) deaths/year. 
For RCP8.5, we propagate input uncertainty to the mortality estimates. Global mortality 
rises from 264,000 (-39,300 to 648,000) in 2030 to 316,000 (-187,000 to 1,380,000) in 2100. 
Uncertainty in RR leads to coefficients of variation (CV) ranging from 31 to 37% (2030), 31 to 
40% (2050) and 16 to 47% (2100) for the different models. Considering the spread of model 
results, CV for the multi-model average mortality increases to 66% (2030), 78% (2050) and 
125% (2100). While uncertainty in RR and in modeled ozone concentrations have similar 
contributions to overall uncertainty in mortality results in 2050 (51% and 49%, respectively), in 
2030 modeled ozone concentrations are the greatest contributor (81%), and in 2100 uncertainty 
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in RR contributes the most to overall uncertainty (88%). For 2030, HadGEM2 differs in signal 
from the other 13 models with an average value for global mortality of -33,900 deaths/year. For 
2050, LMDzORINCA differs substantially from the other 3 models with -38,900 deaths/year. 
For 2100 HadGEM2 is a noticeable outlier with 1.2 million deaths/year and MOCAGE differs in 
sign from the other 12 models with -159,000 deaths/year. 
Increases in global ozone-related mortality relative to 2000 concentrations (Figures 3.2 
and 3.3) are noticeable in some regions through 2030 for all RCPs, particularly in India and East 
Asia for RCP8.5 (124,000 and 127,000 deaths/year, respectively), but all scenarios show 
reductions in global ozone-related mortality in 2100, except RCP8.5. Under this scenario, in 
2100, there are increases in ozone concentrations in all regions except North America, East Asia 
and Southeast Asia (Figure B.2), likely driven by the projected large increase in methane 
emissions as well as by climate change. Decreases in mortality in those three regions of over -
140,000 deaths/year are outweighed by increases in India (292,000 deaths/year), Africa (128,000 
deaths/year) and the Middle East (29,800 deaths/year). Also, some regions show different trends 
in future mortality relative to 2000 depending on the RCP, reflecting the effects of distinct 
assumptions in each RCP about economic growth and air pollution control, as different regions 
grow at different rates.   For example, North America and Europe show decreases in mortality 
through 2100 in all scenarios, except a slight increase in Europe for RCP8.5 in 2100. In East 
Asia, mortality peaks in 2050 for RCP6.0 but it peaks in 2030 for the other three RCPs. India 
shows peaks in mortality in 2050 followed by decreases for all RCPs but RCP8.5, and an 
increase through 2100 in this scenario. Africa shows increases in mortality through 2100 for 
RCP2.6 and RCP8.5, while it peaks in 2050 for RCP4.5 and decreases through 2100 for RCP6.0. 
Also, the effect of changes in population and baseline mortality rates is noticeable in some 
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regions when comparing the trends in total ozone-related mortality and mortality per million 
people in each region (Figure B.8). For example, decreases in population projected for 2100 in 
Europe, FSU and East Asia, are reflected in greater changes in mortality per million people than 
in total mortality, while the trifold increase in population in Africa amplifies the changes in total 
mortality. 
Global PM2.5-related mortality decreases substantially in all scenarios relative to 2000 
concentrations, particularly in 2100 (Figures 3.4 to 3.6, Tables B.8 and B.9). In 2030, the 
decrease varies from -6,180 (RCP8.5) to -289,000 (RCP4.5) deaths/year, although one model 
(CICERO-OsloCTM2) shows increases in mortality for RCP2.6 and RCP8.5. In 2050, there are 
considerable decreases in mortality for all scenarios except RCP6.0 which shows a small 
increase (16,700 deaths/year), but this is the average of only three models that do not agree on 
the sign of the change. In 2100, all scenarios show a major decrease in mortality, reflecting the 
substantial decrease in emissions of primary PM2.5 and precursors: -1.93 million (RCP2.6), -2.39 
million (RCP4.5), -1.76 million (RCP6.0) and -1.31 million (RCP8.5) deaths/year. 
Considering the results of the MC simulations for RCP8.5, premature mortality changes 
from -17,200 (-386,000 to 661,000) in 2030 to -1.31 (-2.04 to -0.17) million in 2100 (Figure 3.8). 
Uncertainty in RR leads to a CV of 11 to 191% for the different models in the three future years. 
The spread of model results increases overall CV to 1644% (2030), 20% (2050) and 41% (2100). 
Uncertainty in modeled PM2.5 concentrations in 2000 is the greatest contributor to overall 
uncertainty (59% in 2030, 45% in 2050, and 49% in 2100), followed by uncertainty in modeled 
PM2.5 concentrations in future years (40% in 2030, 26% in 2050 and 32% in 2100). Uncertainty 
in RR has a negligible contribution to overall uncertainty in 2030 (<1%), as the multi-model 
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mean mortality change happens to be near zero (one model projects a large increase while the 
other five models project decreases), but contributes 29% in 2050 and 20% in 2100. 
In several regions (North America, South America, Europe, FSU and Australia), PM2.5 
mortality decreases through 2100, relative to 2000, for all RCPs. However, in East Asia, 
Southeast Asia, India, Africa, and the Middle East, for some scenarios, PM2.5 mortality increases 
through 2030 or 2050, before decreasing. In East Asia, mortality peaks in 2030 for RCP8.5 and 
in 2050 for RCP6.0. In Southeast Asia, mortality peaks in 2030 for RCP2.6 and in 2050 for 
RCP6.0. In India, mortality peaks in 2050 for all RCPs except RCP8.5 which still shows an 
increase in 2100. In Africa, mortality increases through 2100 for RCP2.6 and RCP8.5, but for 
RCP4.5 it peaks in 2050 and for RCP6.0 it decreases through 2100. The changes in future 
mortality reflect changes in future PM2.5 concentrations relative to 2000 (Figure B.3), and a 
substantial increase in exposed population through the 21
st
 century, particularly in Africa, India 
and the Middle East (Figure B.6). The decreases in population in Europe, FSU and East Asia 
have similar effects as those mentioned above for ozone-related mortality. For example, while 
total avoided mortality in 2100 in East Asia decreases compared to 2050, for RCP2.6, RCP4.5 
and RCP8.5, total avoided mortality per million people increases in the same scenarios (Figure 
B.9). 
We compared mortality results using our own estimates of PM2.5 from the sum of 
reported species with results using PM2.5 reported by four models (Figure 3.7). The multi-model 
average future decrease in mortality for the four models which reported PM2.5 is comparable 
although lower than the average for our PM2.5 estimates for the same models, but higher than the 
average for all six models in 2030 and of lower magnitude in 2100. Individual models do not 
show the same differences in mortality using their own or our PM2.5 estimates. Also, for two 
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models (GFDL-AM3 and MIROC-CHEM) the two sources of PM2.5 estimates yield mortality 
changes of different sign in 2030.These results reflect the different formulas used by each model 
to estimate PM2.5. 
We also estimate the global burden on mortality of ozone and PM2.5 concentrations in the 
future, considering the four RCPs relative to preindustrial concentrations (1850) and future 
exposed population and baseline mortality rates (Figures 8 and 9, Tables B.10 and B.11). For 
context, we estimate the global burden in 2000 (using present-day population from Landscan 
2011 Population Dataset and baseline mortality rates from GBD2010): 382,000 (121,000 to 
728,400) ozone deaths/year and 1.70 (1.30 to 2.10) million PM2.5 deaths/year. These estimates 
are 19% lower than those obtained in our previous study (Silva et al., 2013), reflecting more 
restrictive mortality outcomes (chronic respiratory diseases rather than all respiratory diseases, 
and IHD+STROKE+COPD rather than all cardiopulmonary diseases), updated population and 
baseline mortality rates, and the use of the recent IER model (Burnett et al., 2014) for PM2.5 
(instead of Krewski et al., 2009).  For ozone, the global mortality burden increases in all RCPs 
through 2050 and then it decreases (slightly for RCP8.5 and substantially for the other RCPs). 
The increase can be explained by the rise in the baseline mortality rates for chronic respiratory 
diseases magnified by the increase in exposed population, while the decline is likely mostly 
related to the decrease in concentrations, slightly countered by further population growth (Figure 
3.8). The global burden of PM2.5 shows a declining trend for all RCPs to 2100, except RCP6.0 
which peaks in 2050 before declining considerably. For PM2.5, the increase in exposed 
population and the decline in concentrations have a much greater effect than changes in baseline 
mortality rates (Figure 3.9).  
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To help explain differences between the trends in future global burden (Figures 3.8 and 
3.9) and in future mortality relative to 2000 (Figures 3.1 and 3.4), we estimate the global burden 
in the future years for two cases: Case A - using 2000 concentrations relative to 1850 and 
present-day population but future baseline mortality rates; Case B – using 2000 concentrations 
relative to 1850 but population and future baseline mortality rates. Case A reflects the effect of 
future baseline mortality rates on the global burden, if concentrations in future years were 
maintained at 2000 levels, while Case B reflects the combined effect of population and baseline 
mortality rates. The difference between the global burden for each RCP and Case B reflects the 
effects of changes in future air pollutant concentrations, and nearly equals future mortality 
relative to 2000 concentrations in Figures 3.1 and 3.4. However, Cases A and B are calculated 
for all 14 models for ozone and 6 models for PM2.5, while future mortality relative to 2000 is 
calculated for the models that report each scenario/year. Also, for ozone, 17% higher estimates, 
on average, for future mortality should be due to non-linearities in the calculation. Thus, Figures 
3.8 and 3.9 should not be compared directly with Figures 3.1 and 3.4, respectively.  
 
3.3.2 Impact of future climate change 
 
While our previous study using the ACCMIP ensemble (Silva et al., 2013) showed that 
anthropogenic increases in emissions were a much greater contributor than past climate change 
to present-day air pollution-related mortality, here future climate change is estimated to 
contribute considerably more to future mortality in 2100 relative to 2000. 
We estimate that global ozone mortality will increase due to climate change in RCP8.5 
by 10,600 (-29,700 to 86,200) deaths in 2030 but rise to 127,000 (-193,000 to 1.07 million) 
deaths in 2100 (Figures 3.10 to 3.12, Table B.12, Figure B.10). In 2100, ozone mortality 
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increases in all regions but Africa, especially in highly populated and highly polluted areas, with 
marked spatial differences within regions. The effect on ozone mortality in 2100 is the strongest 
in East Asia (64,600 deaths/year, 58 deaths/year per million people), India (40,100 deaths/year, 
20 deaths/year per million people) and North America (13,100 deaths/year, 17 deaths/year per 
million people), but some areas in these and other regions show decreases in mortality. 
Considering the number of models showing an increase in ozone concentrations in 2100 relative 
to 2000 due to climate change in RCP8.5 (Figure 3.13), there are robust increases in 
concentrations in some polluted regions, such as the northeast US, and robust decreases in the 
tropics over the oceans. Climate change contributes 40% of the overall increase in ozone 
mortality estimated for RCP8.5 in 2100 relative to 2000 concentrations (Figure 3.1) and 5% of 
the global burden under RCP8.5 in 2100.  Three of 9 models in 2030 and three of 10 in 2100 
show decreases in future ozone mortality due to climate change.  Propagating uncertainty in RR 
to the ozone-related mortality due to climate change leads to CVs of 31-34% for the different 
models but the spread of model results increases overall CVs to 266% in 2030 and 228% in 
2100, mostly due to the unusually high results from EMAC. Uncertainty in modeled ozone 
concentrations contributes over 96% to the overall uncertainty in both 2030 and 2100. The multi-
model average mortality estimates without including the EMAC results are: 3,340 (-30,300 to 
47,100) in 2030 and 43,600 (-195,000 to 237,000) in 2100. 
The impact of climate change on PM2.5 mortality is estimated to result in 55,600 (-34,300 
to 164,000) deaths in 2030 and 215,000 (-76,100 to 595,000) deaths in 2100 (Figures 3.14 to 
3.16, Table B.13, Figure B.11). Propagating uncertainty in RR to the mortality estimates leads to 
CVs of 8-31% (2030) and 11-46% (2100) for the different models, but the spread of model 
results increases overall CVs to 123% in 2030 and 106% in 2100. In both periods, one model 
 49 
(GISS-E2-R) shows a decrease in mortality while the other three (2030) or four (2100) show an 
increase. Uncertainty in modeled PM2.5 concentrations in 2000 has a similar contribution to 
overall uncertainty (50% in 2030 and 52% in 2100) than uncertainty in modeled PM2.5 
concentrations in future years (50% in 2030, 48% in 2100). Uncertainty in RR has a negligible 
contribution in both periods (<1%), as the multi-model mean is small and different models 
disagree on the sign of the influence. PM2.5 mortality increases in 2100 in all regions except 
Africa (-26,000 deaths/year). The greatest increases in mortality in 2100 occur in India (82,100 
deaths/year, 41 deaths/year per million people), Middle East (50,300 deaths/year, 44 deaths/year 
per million people) and East Asia (48,900 deaths/year, 44 deaths/year per million people), 
however FSU shows greater mortality per million people in 2100 (57 deaths/year per million 
people). Similar to ozone mortality, there are substantial spatial differences within the different 
regions, with some areas in regions other than Africa showing decreases in mortality. There is 
considerable agreement among models regarding the increase in PM2.5 concentrations in many 
locations in 2100 due to climate change in RCP8.5 (Figure 3.17). For PM2.5, a large decrease in 
mortality is projected in RCP8.5 relative to 2000 (due to emissions and climate change), but 
climate change alone contributes an increase in mortality, thus reducing the potential decrease 
associated with declining emissions in that scenario. Without climate change, the decrease in 
mortality would be roughly 16% greater. Climate change contributes 14% of the global burden 
under RCP8.5 in 2100. 
Mortality results using PM2.5 reported by four models are higher than results with our 
estimates of PM2.5 from the sum of reported species: 15% in 2030 and 12% in 2100 (Figure 
3.18). There are different degrees of agreement between the two estimates among the four 
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models, and for one model (GISS-E2-R) the two sources of PM2.5 estimates yield impacts of 




The importance of conducting health impact assessments with air pollutant 
concentrations from model ensembles, instead of single models, is highlighted by the differences 
in sign of the change in mortality among models, and by the marked impact of the spread of 
model results on overall uncertainty in our mortality estimates. In most cases assessed here 
(future ozone mortality in 2030 relative to 2000, future PM2.5 mortality in 2030, 2050 and 2100 
relative to 2000, and impact of climate change on ozone and PM2.5 mortality in 2030 and 2100), 
uncertainty in modeled air pollutant concentrations contributes the most to uncertainty in 
mortality estimates. Uncertainty in future ozone mortality in 2050 relative to 2000 has 
comparable contributions from uncertainty in RR and modeled concentrations, while in 2100 
uncertainty in RR contributes the most to overall uncertainty in ozone mortality..  
Our estimates for the impact of climate change in RCP8.5 in the US for ozone (1,380 
deaths/year in 2030; 11,700 deaths/year in 2100) and PM2.5 (6,900 deaths/year in 2030 and 
19,400 deaths/year in 2100) compare well with the estimate for ozone-related deaths in 2030 of 
Fann et al. (2015), who report 420 to 1900 ozone-related deaths in the US depending on the 
concentration-response factor (CRF). Fann et al. (2015) also considered climate change in 
RCP8.5, but used different CRFs and sources of population and baseline mortality projections. 
Our results are also consistent with the increases in mortality and spatial variability in 2050 in 
the US estimated by Bell et al. (2007) for ozone and Tagaris at al. (2009) for ozone and PM2.5, 
although these two studies used different scenarios besides other methodological differences.  
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Across models, our estimates for ozone mortality in the US vary between -435 and 4,750 
deaths/year in 2030 and between -1,820 and 37,300 deaths/year in 2100. This spread of model 
results, with a few models suggesting avoided mortality due to climate change, is similar to that 
of Post et al. (2012) in 2050 (-600 to 2,500 deaths/year) using SRES scenarios of GHG 
emissions. Other regions also show variability in mortality estimates within the region (Figures 
3.11 and 3.15). For example, we estimate increases in ozone and PM2.5 mortality for Europe, 
particularly in 2100 (5,500 and 9,800 deaths/year, respectively), but, as Orru et al. (2013) report 
for mid-21st century for the A2 and A1B SRES scenarios, we find considerable spatial 
variability across the region, with increases in mortality in Central and Southern Europe and 
decreases in Northern Europe. 
There are several uncertainties and assumptions that affect our results. We applied the 
same RR worldwide and into the future, despite differences in vulnerability of the exposed 
population, in composition of PM2.5, and in other factors that may support the use of different 
risk estimates or different concentration-response relationships. Also, we estimate mortality for 
adults aged 25 and older, and we do not quantify air pollutant effects on morbidity, so we may 
underestimate the overall impact of changes in pollutant concentrations on human health. 
Uncertainties in projections of future population and baseline mortality rates were not included 
in our estimates of uncertainty, and the spread of model results does not account for uncertainty 
in emissions inventories, as ACCMIP models used the same anthropogenic emissions.  
These uncertainties can be addressed through additional long-term epidemiological 
studies, particularly for large cohorts in developing countries, to improve RR estimates globally. 
These studies should be representative of wider ranges of exposure and air pollutant mixtures 
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than existing studies in the US and Europe, and they should control well for confounding factors 
such as other environmental exposures, use of air conditioning, socio-economic factors, etc.  
Also, the effect of climate change on air quality is highly uncertain.  Further 
improvements in chemistry climate models are needed to better model the interaction and 
feedbacks between climate and air quality, including the sensitivity of biogenic emissions to 
climate change, the effects of meteorological changes on air quality, including aerosol-cloud 
interactions and their effect on regional precipitation, and the impact of climate change on 
wildfires. Stratosphere-troposphere interactions (e.g. stratospheric influx of ozone) are also 
important, as is the impact of land use changes on regional climate and air pollution. 
Our results are limited by the range of projected air pollutant emissions given by the 
RCPs. All RCPs consider reductions in anthropogenic precursor emissions associated with more 
extensive air quality legislation as incomes rise, except for methane in RCP8.5 and for ammonia 
in all scenarios.  These scenarios together do not encompass the range of plausible air pollution 
futures for the 21
st
 century, as the RCPs were not designed for this purpose.  Other plausible 
scenarios have been considered, such as the Current Legislation Emissions and Maximum 
Feasible Reductions scenarios used by Likhvar et al. (2015).  If economic growth does not lead 
to stricter air pollution control, emissions may rise considerably, particularly for scenarios of 
high population growth in developing countries. In contrast, the RCPs do represent a range of 
plausible climate futures, but the ACCMIP models only isolated the effects of climate change on 







Under the RCP scenarios, global PM2.5 mortality generally decreases in the future relative 
to 2000 concentrations, but ozone mortality increases in some scenarios/periods. Ozone-related 
mortality is likely to increase in 2100 for RCP8.5 with an estimate of 316,000 (-187,000 to 
1,380,000) deaths/year (likely due to an increase in methane emissions and to the effect of 
climate change), while for the three other RCPs ozone mortality in 2100 decreases relative to 
2000: -718,000 (RCP6.0), -917,000 (RCP4.5) and -1.02 million (RCP2.6) deaths/year. For PM2.5, 
mortality is estimated to decrease to -1.33 (RCP8.5), -1.76 (RCP6.0), -1.93 (RCP2.6) and -2.39 
(RCP4.5) million deaths/year in 2100 relative to 2000. These reductions in ambient air pollution-
related mortality reflect the decline in most emissions projected in the RCPs. Mortality estimates 
differ among models and we find that, for most scenarios, the contribution to overall uncertainty 
from uncertainty associated with modeled air pollutant concentrations exceeds that from the 
RRs. Increases in exposed population and in baseline mortality rates of respiratory diseases 
magnify the impact on mortality of the changes in air pollutant concentrations. Estimating future 
mortality relative to 2000 concentrations allows us to emphasize the effects of changes in air 
pollution in these results. However increases in exposed population and baseline mortality rates 
may drive an increase in the future burden of air pollution on mortality. Even in the most 
optimistic scenarios, the global mortality burden of ozone is estimated to be over 1 million 
deaths/year in 2100, compared to less than 0.4 million in 2000 (Figure 3.8). For PM2.5, the global 
burdens in 2030 and 2050, for the four RCPs, are greater than the global burden in 2000: 
between 2.4 and 2.6 million deaths/year in 2030 and between 1.8 and 3.5 million deaths/year in 
2050, compared to 1.7 million deaths/year in 2000 (Figure 3.9). 
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We also estimate that climate change under RCP8.5 will likely increase global air 
pollution-related mortality, particularly in 2100: 127,000 (-193,000 to 1.1 million) ozone-related 
deaths and 215,000 (-76,100 to 595,000) PM2.5-related deaths. Climate change is estimated to 
increase ozone and PM2.5 mortality in all regions except Africa, especially in highly populated 
and highly polluted areas. Action to mitigate climate change will benefit human health by 
reducing its effect on air quality and reducing co-emitted air pollutants (West et al., 2013), as 
well as by reducing many other influences that climate change has on human health (Smith et al., 
2014). Uncertainty in modeled ozone concentrations contributes the most to uncertainty in 
mortality estimates, both for ozone and PM2.5, as future mortality is estimated to decrease due to 
climate change by three models for ozone and one model for PM2.5. Therefore, results from 
studies using a single model should be interpreted cautiously. 
The RCPs are based on the premise that economic development drives better air pollution 
control, leading to improved air quality. This trend is apparent in some developing countries 
now, but it is yet to be determined how aggressive many developing nations will be in addressing 
air pollution. The assumed link between economic development and air pollution control in the 
RCPs requires new and stronger regulations around the world, as well as new control 
technologies, in order for the air pollution decreases in the RCPs to be realized.  The reductions 







3.6 Tables and Figures 
 
 
Figure 3.1 – Estimates of future ozone respiratory mortality for all RCP scenarios in 2030, 2050 and 2100, showing global mortality 
for 13 models and the multi-model average (million deaths/year), for future air pollutant concentrations relative to 2000 
concentrations. Uncertainty for the multi-model average shown for RCP8.5 is the 95% CI including uncertainty in RR and across 




Figure 3.2 – Future ozone respiratory mortality for all RCP scenarios in 2030, 2050 and 2100, 
showing the multi-model average in each grid cell, for future air pollutant concentrations relative 








Figure 3.3 – Future ozone respiratory mortality for all RCP scenarios in 2030, 2050 and 2100, showing the multi-model regional 








Figure 3.4 – Estimates of future premature mortality (IHD+STROKE+COPD+LC) for PM2.5 calculated as a sum of species, for all 
RCP scenarios in 2030, 2050 and 2100, showing global mortality for six models and the multi-model average (million deaths/year), 
for future air pollutant concentrations relative to 2000 concentrations. Uncertainty shown for RCP8.5 for the multi-model average is 





Figure 3.5 – Future premature mortality (IHD+STROKE+COPD+LC) for PM2.5 calculated as a 
sum of species, for all RCP scenarios in 2030, 2050 and 2100, showing the multi-model average 







Figure 3.6 – Future premature mortality (IHD+STROKE+COPD+LC) for PM2.5 calculated as a sum of species, for all RCP scenarios 
in 2030, 2050 and 2100, showing the multi-model regional average (deaths/year) in ten world regions (Figure B.1) and globally, for 






Figure 3.7 – Estimates of global future premature mortality (IHD+STROKE+COPD+LC) for RCP8.5 in 2030 and 2100, for PM2.5 
reported by four models and PM2.5 estimated as a sum of species for the same four models and for six models, showing global 
mortality for each model and the multi-model average (million deaths/year), for future air pollutant concentrations relative to 2000 
concentrations. Models signaled with * reported their own estimate of PM2.5. Uncertainty shown for the average of six models for sum 




Figure 3.8 –  Global burden on mortality of ozone concentrations relative to 1850, in the present 
day for 2000 concentrations, showing multi-model average and 95% CI including uncertainty in 
RR and across models (deaths/year), and in 2030, 2050 and 2100 for all RCPs, showing multi-
model averages (deaths/year) given by the deterministic values. Also shown are future burdens 
using (Case A) 2000 concentrations relative to 1850 and present-day population but future 
baseline mortality rates and (Case B) 2000 concentrations relative to 1850 but future population 
and baseline mortality rates. 
 
 
Figure 3.9 –  Global burden on mortality of PM2.5 concentrations relative to 1850, in the present 
day for 2000 concentrations, showing multi-model average and 95% CI including uncertainty in 
RR and across models (deaths/year), and in 2030, 2050 and 2100 for all RCPs, showing multi-
model averages (deaths/year) given by the deterministic values. Also shown are future burdens 
using (Case A) 2000 concentrations relative to 1850 and present-day population but future 
baseline mortality rates and (Case B) 2000 concentrations relative to 1850 but future population 




Figure 3.10 – Estimates of the impact of RCP8.5 climate change on ozone respiratory mortality 
in 2030 and 2100, showing global mortality for 10 models and the multi-model average 
(deaths/year). Uncertainty for the multi-model average is the 95% CI including uncertainty in RR 





Figure 3.11 – Impact of climate change on ozone respiratory mortality in 2030 and 2100, 




Figure 3.12 – Impact of climate change on ozone respiratory mortality in 2030 and 2100, 




Figure 3.13 - Number of models with positive change in ozone concentrations due to climate 




Figure 3.14 – Estimates of the impact of RCP8.5 climate change on future premature mortality 
(IHD+STROKE+COPD+LC) in 2030 and 2100 for PM2.5 calculated as a sum of species, 
showing global mortality for five models and the multi-model average (deaths/year). Uncertainty 




Figure 3.15 – Impact of climate change on premature mortality (IHD+STROKE+COPD+LC) in 
2030 and 2100 for PM2.5 calculated as a sum of species, showing the multi-model average in 





Figure 3.16 – Impact of climate change on premature mortality (IHD+STROKE+COPD+LC) in 
2030 and 2100 for PM2.5 calculated as a sum of species, showing the multi-model regional 
average (deaths/year) in ten world regions (Figure B.1) and globally. 
 
 
Figure 3.17 - Number of models with positive change in PM2.5 concentrations due to climate 







Figure 3.18 – Estimates of the impact of RCP8.5 climate change on future premature mortality (IHD+STROKE+COPD+LC) in 2030 
and 2100 for PM2.5 reported by four models and PM2.5 estimated as a sum of species for four models in 2030 and five models in 2100, 
showing global mortality for each model and the multi-model average (million deaths/year). Models signaled with * reported their 
own estimate of PM2.5. Uncertainty shown for the multi-model average for sum of species is the 95% CI including uncertainty in RR 





CHAPTER 4 - THE IMPACT OF INDIVIDUAL ANTHROPOGENIC EMISSIONS 







Rising anthropogenic emissions of air pollutants and their precursors have caused 
significant increases in ambient air pollution (Cooper et al., 2014; Lamarque et al., 2010; Naik et 
al., 2013; Stevenson et al., 2013). Ozone and fine particulate matter (PM2.5) pollution is 
particularly important for public health. Short-term exposure to ozone causes respiratory 
morbidity and mortality (Bell et al., 2014; Gryparis et al., 2004; Levy et al., 2005; Stieb et al., 
2009) and long-term exposure has been associated with premature respiratory mortality in adults 
(Jerrett et al., 2009) and increased risk of death in susceptible populations with chronic 
cardiopulmonary diseases and diabetes (Zanobetti and Schwartz, 2011). Exposure to PM2.5 can 
have detrimental acute and chronic health effects, including premature mortality due to 
cardiopulmonary diseases and lung cancer (Brook et al., 2010; Burnett et al., 2014; Hamra et al., 
2014; Krewski et al., 2009; Lepeule et al., 2012).  
The global burden of disease (GBD) due to ambient air pollution was first estimated for 
urban exposure to PM2.5 based on surface measurements (Cohen et al., 2004). More recent 
studies have covered both urban and rural regions using output from global atmospheric models 
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(Anenberg et al., 2010; Fang et al., 2013; Lelieveld et al., 2013; Rao et al., 2012), or global 
modeling output combined with observations (Evans et al., 2013; Lim et al., 2012), to estimate 
exposure to PM2.5 and ozone. Our research group previously used output from an ensemble of 
global chemistry-climate models to estimate 2.1 million premature deaths/year associated with 
anthropogenic PM2.5 and 470,000 ozone-related deaths/year (Silva et al., 2013).  
Here we use a global chemical transport model at fine horizontal resolution to estimate: 
 The global and regional mortality burden of anthropogenic ozone and PM2.5; 
 The impact of removing emissions from each of five anthropogenic emissions sectors 
(Energy, Residential & Commercial, Industry, Land Transportation, Shipping & 
Aviation) to current ozone and PM2.5 premature mortality. 
Understanding how different sectors impact the global burden and the relative importance 
of each emissions source sector among regions/countries can help prioritize national and 
international air pollution control strategies. Although the impact of different sectors on health 
has been quantified in the U.S. (Caiazzo et al., 2013; Fann et al., 2013) and Europe (Andersson 
et al., 2009; Brandt et al., 2013), previous global studies focus on one specific sector– Shipping 
(Corbett et al., 2007), Aviation (Barrett et al., 2010) and Land Transportation (Chambliss et al., 
2014). Chambliss et al. (2014) used output from the same baseline and land transportation 
simulations as the present study, but a different method to estimate global PM2.5 mortality. They 
calculated the fraction of total PM2.5 concentrations attributable to surface transportation 
emissions which they applied to the total PM2.5 concentrations estimated by Brauer et al. (2012) 
to obtain a country-level attributable fraction, and finally applied this fraction to the country 
mortality estimates from GBD 2010 (Lim et al., 2012).  
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Estimates of health impacts using output from global models are limited by the coarse 
resolution of the models that are incapable of resolving fine gradients in air pollutant 
concentrations, particularly near urban areas. Coarse resolution estimates are expected to 
underestimate PM2.5-related mortality, mostly due to the smoothing of high urban concentrations, 
with smaller bias for ozone-related mortality, as ozone has smaller urban-rural gradients than 
PM2.5 (Li et al., 2015; Punger and West, 2013).  We attempt to minimize these errors by 
conducting simulations at a finer horizontal resolution (0.67°x0.5°) than previous global 
modeling studies assessing health impacts (1°x1° to 2.8°x2.8°). We also quantify the bias in 





4.2.1 Modeled ozone and PM2.5 concentrations 
 
We simulate ozone and PM2.5 concentrations for 2005, using the Model for Ozone and 
Related Chemical Tracers, version 4 (MOZART-4). MOZART-4 includes a chemical 
mechanism with detailed hydrocarbon chemistry and bulk aerosols, and online representations of 
several processes such as dry deposition, biogenic emissions of isoprene and monoterpenes, and 
photolysis frequencies (Emmons et al., 2010). Anthropogenic and biomass burning emissions are 
from the IPCC AR5 Representative Concentration Pathway 8.5 global emissions inventory for 
2005 (Riahi et al., 2007; Van Vuuren et al., 2011a) (Supplemental Material, Appendix C). 
Biogenic emissions of isoprene and monoterpenes were calculated online in MOZART-4 using 
the Model of Emissions of Gases and Aerosols from Nature (MEGAN) (Guenther et al., 2006). 
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All other natural emissions were taken from Emmons et al. (2010) and held constant in all 
scenarios. The model was run at a 0.67° longitude by 0.5° latitude horizontal resolution with 72 
vertical hybrid (sigma and pressure) levels, driven by GEOS-5 meteorological fields. Each 
simulation was run for 18 months, including 6 months spin-up. Surface concentrations are from 
the lowest vertical level (992.5 mb at the layer midpoint). 
Considering our baseline simulation, modeled surface concentrations show similar 
agreement with observations as other global models (Supplemental Material, Appendix C), and 
as previous MOZART-4 simulations at a coarser resolution using the same meteorology and 
emissions inputs (Fry et al., 2013). Additionally, we ran a simulation with no anthropogenic 
emissions to estimate the total mortality burden of present-day anthropogenic ozone and PM2.5. 
Both simulations were also run at a coarser resolution (2.5°x1.9°) to estimate the bias relative to 
the fine resolution. 
The impact of removing emissions from each source sector was quantified using a brute-
force sensitivity analysis, where five emissions sectors are zeroed-out individually: All 
Transportation, Land Transportation, Energy, Industry, and Residential & Commercial. Land 
Transportation is a subset of All Transportation; we estimate the impact of Shipping & Aviation 
as the difference.  This zero-out method has been used in previous studies to evaluate the 
contribution of different regions and/or sectors to ambient air pollutant concentrations (e.g. 
Andersson et al., 2009; Caiazzo et al., 2013; Corbett et al., 2007; Koch et al., 2007; Li et al., 
2015). Due to non-linearity in model response to changes in emissions (e.g. reduction in 
emissions may lead to a NOx-limited regime for ozone chemistry), estimates of the impacts of a 
sector using the zero-out method may differ from those using other methods (e.g., source 
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tracking), and the sum of source impacts over all sectors may differ from the total in the baseline 
simulation (Cohan et al., 2005; Koo et al., 2009; Kwok et al., 2015). 
 Modeled concentrations in each grid cell were processed to obtain the metrics used in the 
health impact assessment, consistent with the underlying epidemiological studies (Burnett et al., 
2014; Jerrett et al., 2009; Krewski et al., 2009): annual average PM2.5 and the average 1-hr daily 
maximum ozone for the consecutive 6-month period with the highest average. PM2.5 
concentrations were estimated as a sum of modeled species (Supplemental Material, Appendix 
C).  
 
4.2.2 Health impact assessment 
 
We estimate cause-specific excess mortality due to exposure to ambient air pollution 
(∆Mort) in each MOZART-4 grid cell as ∆Mort = y0 * AF *Pop, where y0 is the baseline 
mortality rate (for the exposed population), AF = 1 – 1/RR is the attributable fraction (RR = 
relative risk of death attributable to change in pollutant concentration), and Pop is the exposed 
population (adults aged 25 and over). 
For ozone, AF = 1-exp
-β∆X
, where RR = exp
β∆X, β is the concentration-response factor, 
∆X corresponds to the change in pollutant concentrations, and RR = 1.040 (95% Confidence 
Interval, CI: 1.013-1.067) for a 10 ppb increase in ozone concentrations (Jerrett et al., 2009), 
since this is the largest cohort study that estimated RR for long-term exposure to ozone. 
Although Jerrett et al. (2009) estimated RR for adults aged 30 and over, we consider adults aged 
25 and over, assuming identical RR, to align exposed populations for ozone and PM2.5, following 
Lim et al. (2012). However, we evaluate ozone mortality due to all chronic respiratory diseases 
(ICD-9 BTL: B347) based on Jerrett et al. (2009), as in other global studies (Anenberg et al., 
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2010; Fang et al., 2013; Lelieveld et al., 2013; Silva et al., 2013), while Lim et al. (2012) 
considered only chronic obstructive pulmonary disease (COPD) mortality (78% of global 
chronic respiratory disease mortality, ranging from 27% to 93% across 187 countries). 
For PM2.5, we use the Integrated Exposure-Response (IER) model developed for GBD 
2010 (Burnett et al., 2014), which is intended to better estimate excess mortality at high PM2.5 
concentrations: 
𝑅𝑅𝐼𝐸𝑅(𝑧) =  {
1,                                                    𝑧 <  𝑧𝑐𝑓
1 +  𝛼(1 − 𝑒−𝛾(𝑧−𝑧𝑐𝑓)
𝛿
)            𝑧 ≥  𝑧𝑐𝑓 
 
 
where z is PM2.5  concentration and zcf  = counterfactual concentration (theoretical 
minimum-risk exposure, assumed by Burnett et al. (2014) to have a uniform distribution: zcf 
~U[5.8,8.8]). 
We use the RRs given by IER for mortality due to ischemic heart disease (IHD, ICD-9: 
410-414), cerebrovascular disease (Stroke, ICD-9: 430-435, 437.0-437.2, 437.5-437.8), COPD 
(ICD-9: 490-492.8, 494, 496) and lung cancer (LC, ICD-9 BTL: B101). We calculate AF=AF1-
AF2, where AF1 = 1-1/RRIER(z1) and AF2 = 1-1/RRIER(z2), z1 = baseline concentration, z2 = 
concentration in control simulation.  
We define the mortality burden of anthropogenic air pollution as air pollution that is 
controllable, using the simulation with no anthropogenic emissions to estimate ∆X for ozone, 
and z2 for PM2.5, following Anenberg et al. (2010), Fang et al. (2013), Lelieveld et al. (2013), 
and Silva et al. (2013).  This approach differs from GBD 2010, which considers total PM2.5 
relative to zcf (AF = AF1). Where natural PM2.5 is below zcf (i.e. AF2 = 0), our estimate of excess 
mortality is identical to the total PM2.5 mortality burden. If natural PM2.5 concentrations are 
above zcf (e.g. dusty regions), we estimate mortality due to anthropogenic air pollution only. 
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Whereas Giannadaki et al. (2014) quantify the contribution of desert dust to global mortality, it is 
considered natural PM2.5 under our definition. As a sensitivity analysis, we also use the 
log−linear function, considering RR for CPD and LC from Krewski et al. (2009) as other recent 
global health impact assessments (Anenberg et al., 2010; Evans et al., 2013; Fang et al., 2013; 
Lelieveld et al., 2013; Silva et al., 2013). 
Exposed population was obtained from the Oak Ridge National Laboratory's Landscan 
2011 Global Population Dataset at approximately 1 km resolution (30"x30") (Bright et al. 2012). 
For adults aged 25 and over, we estimated population per 5-year age group in each cell by 
multiplying the country-level percentage in each age group (from Landscan) by the total cell 
population, using ArcGIS 10.2 geoprocessing tools. Cause-specific baseline mortality rates for 
187 countries were obtained from the GBD 2010 mortality dataset (Global Burden of Disease 
Study, 2010). We estimated the number of deaths per 5-year age group per country using the 
country level population from Landscan and gridded using ArcGIS 10.2. The resulting 
population and baseline mortality per age group at 30"x30" were regridded to the resolutions of 
the atmospheric model (0.67°x0.5° and 2.5°x1.9°). 
We conducted 1000 Monte Carlo simulations to propagate uncertainty from the RRs, 
baseline mortality rates, and modeled air pollutant concentrations. For ozone RRs, we used the 
reported 95% confidence intervals (CIs) and assumed a normal distribution. For PM2.5 RRs, we 
used the parameter values of Burnett et al. (2014) for 1000 simulations. Also, we considered the 
reported 95% CIs for baseline mortality rates, assuming lognormal distributions. Finally, for 
modeled ozone and PM2.5 concentrations we used the absolute value of the coefficient of 
variation at each grid cell for the year 2000 minus year 1850 simulations from the ACCMIP 
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multi-model ensemble (Lamarque et al., 2013; Silva et al., 2013), regridded to 0.67°x0.5° and 




The global distributions of ozone and PM2.5 surface concentrations and population-
weighted averages for ten world regions, exposed population, and baseline mortality rates are 
shown in the Supplemental Material (Appendix C). 
We estimate the present-day global burden of anthropogenic ozone-related respiratory 
mortality to be 493,000 (95% CI: 122,000-989,000) deaths/year (Table 4.1). Most mortality 
occurs in East Asia (35%) and India (33%) (Figure 4.1 and Supplemental Material, Appendix C, 
Table C.7). These regions are highly populated and, together with North America, have the 
highest population-weighted average anthropogenic ozone concentrations. While East Asia and 
India have 113 deaths/year per million people due to exposure to ozone, the lowest premature 
mortality rate occurs in Africa (11 deaths/year per million people) (Supplemental Material, 
Appendix C, Table C.9).  For global ozone mortality, the coefficient of variation (CV = standard 
deviation / mean) is 46% and uncertainty from RR and in modeled ozone have similar 
contributions to overall uncertainty (45% each), while uncertainty in baseline mortality rate 
contributes 10%.  
For anthropogenic PM2.5, we estimate a global mortality burden of 2.2 (1.0 - 3.3) million 
deaths/year (Table 4.1), with contributions from IHD (926,000, 436,000 – 1.3 million), Stroke 
(887,000, 439,000 – 1.3 million), COPD (260,000, 79,200 – 477,000) and LC (157,000, 29,800 – 
316,000). The greatest mortality occurs in East Asia (48%), followed by India (18%) and Europe 
(11%) (Figure 4.1 and Supplemental Material, Appendix C, Table C.8), regions with the highest 
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population-weighted average anthropogenic PM2.5. While East Asia has 683 deaths/year per 
million people due to exposure to anthropogenic PM2.5, the lowest mortality rate occurs in Africa 
(32 deaths/year per million people) (Supplemental Material, Appendix C, Table C.10). The 
global CV for PM2.5 mortality is 25%, but global CVs are greater for COPD (40%) and LC 
(46%) than for IHD (25%) and Stroke (26%). Uncertainties in the RR model parameters alpha, 
gamma and delta together have the greatest contribution to overall uncertainty (71.7%) and PM2.5 
concentrations in the baseline simulation have a noticeable contribution (23.3%), but 
concentrations in the simulation with all anthropogenic emissions zeroed-out have a minimal 
contribution (2.3%) as does uncertainty in baseline mortality rates (2.4%). Uncertainty in the 
counterfactual concentration has a negligible contribution (0.2%) to overall uncertainty. When 
considering each disease individually, the contributions of different variables vary from those 
mentioned above, particularly the contribution of PM2.5 concentrations in the baseline simulation 
to IHD mortality uncertainty (33.2%) and to COPD (14.1%) and LC (13.0%) mortality 
uncertainties. 
Globally, the zeroed-out sectors contribute about 57% of total anthropogenic ozone 
mortality (Table 4.1). Land Transportation has the greatest global impact (16%) and the greatest 
regional impact (20 to 26%) in North America, South America, Europe, FSU and Middle East 
(Figures 4.2 and 4.3), as it strongly influences ozone concentrations.  Energy and Residential & 
Commercial also have strong impacts in India and all sectors have important impacts in East 
Asia. Among the deaths caused by each sector worldwide, the greatest impacts occur in India 
and East Asia, particularly by Residential & Commercial (83%), Industry (75%) and Energy 
(74%), reflecting the largest exposed populations in these regions. Within each region, there is 
variability in the impact of removing emissions from different sectors, with a few noticeable 
  
77 
hotspots for certain sectors (e.g. central Africa for Residential & Commercial, eastern North 
America and India for Energy, and eastern East Asia for Industry). The 43% of the total burden 
not accounted for by the five modeled sectors likely reflects sectors not zeroed-out, mainly 
Biomass Burning emissions, increases in methane, and nonlinear model responses such that the 
total may not equal the sum of the impacts of reducing emissions from each sector at a time. 
For anthropogenic PM2.5, the modeled sectors contribute 70% of total global mortality 
(Table 4.1). Residential & Commercial contributes 675,000 (428,000-899,000) deaths/year, 
having the greatest impact globally (30%) and in most regions except North America, South 
America and Australia (Figures 4.4 and 4.5). Land Transportation dominates in North America 
(32% of total anthropogenic PM2.5 mortality in this region), and in Europe it has nearly the same 
burden (24%) as Residential & Commercial (27%). In East Asia, Residential & Commercial 
contributes 21% of total mortality, followed by Industry (17%) and Energy (11%). Among the 
ten regions, Residential & Commercial has the greatest impact in East Asia (33%), followed by 
India (26%). Industry and Energy also impact East Asia the most (55% and 41%). Land 
Transportation has the strongest impact in Europe (27%) and East Asia (23%). The different 
regional impacts are mainly associated with the impact of removing emissions from each sector 
on total anthropogenic PM2.5 concentrations as well as the size of the exposed population and 
baseline mortality rates in each region (e.g. cardiovascular diseases in FSU). Within each region 
the impact of each sector varies reflecting the location of emission sources (e.g.  eastern North 
America for Energy; and small areas in Europe, FSU, southern Africa, eastern South America, 
Middle East and East Asia for Energy and Industry). The 30% of total burden not accounted for 




4.3.1 Sensitivity analyses 
 
4.3.1.1 Fine vs. coarse resolution 
 
We quantified a slight negative bias of 2% for global ozone mortality and a positive bias 
of 16% for global PM2.5 mortality at coarse resolution relative to finer resolution (Supplemental 
Material, Appendix C). These biases differ from those estimated by Punger and West (2013), 
when comparing mortality estimates using output at a fine resolution with mortality estimates 
using that output regridded to coarser resolutions, and by Li et al. (2015), using model output at 
identical resolutions as our study, but regridded to a 12-km resolution. The former study found a 
slight overestimation of ozone mortality at coarse resolutions, and both studies found an 
underestimation of PM2.5 mortality. These discrepancies may be related to the effect of resolution 
on modeled chemistry (e.g. Wild and Prather, 2006), as we perform the health impact assessment 
at the original resolutions of the model output (coarse and finer). 
 
4.3.1.2 Log-linear exposure-response function for PM2.5 
 
Using the log-linear model and RRs of Krewski et al. (2009), we obtain 74% of the 
global burden of anthropogenic PM2.5 mortality estimated with the IER function, with marked 
regional differences (e.g. for North America, mortality estimated with the log-linear model is 
16% higher than using the IER model). We used the RR reported for CPD for IHD, Stroke and 
COPD and the RR reported for LC to allow for a straightforward comparison with the estimate 
using the IER function. IHD and Stroke mortality decrease by 60% and 57%, while COPD and 
LC mortality increase by 131% and 107%. 
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These differences can be explained by the shape of the IER function, which gives 
considerably different estimates of AF for identical changes in PM2.5 concentrations in areas with 
low vs. high total PM2.5 concentrations, such as North America (8.5µg/m
3
) and Middle East 
(27.8 µg/m
3
), with the latter being on the flatter part of the IER curves. Population-weighted 
average changes in concentration (2005 minus natural) for North America and Middle East are 
very close (7.1 and 7.2 µg/m
3
), as are the attributable fractions for CPD (8.2% and 8.3%) and LC 
(9.0% and 9.1%) using the log-linear model. However, using the RRs from the IER model, AFs 
for IHD for North America are between 21% and 6% for all age groups, while for Middle East 





Our global burden estimates are comparable to those of Silva et al. (2013) using an 
ensemble of global models, being 5% greater for ozone mortality and 6% greater for PM2.5 
mortality, although here we use the IER model to estimate PM2.5 mortality. However, our results 
differ from other global ozone mortality estimates: Anenberg et al. (2010) (-30%); Lim et al. 
(2012) (+228%); Fang et al. (2013) (+31%); and Lelieveld et al. (2013) (-36%). For PM2.5 
mortality, our estimates are lower than those of Anenberg et al. (2010) (-40%), Lim et al. (2012) 
(-30%) and Evans et al. (2013) (-18%), but higher than Lelieveld et al. (2013) (+2%) and Fang et 
al. (2013) (+40%).  
Our lower estimates compared to Anenberg et al. (2010) may be related to the finer 
resolution (vs. 2.8°x2.8°) and updates in MOZART-4 (vs. MOZART-2), but are likely due to the 
use of different emissions datasets, different exposure-response functions for PM2.5, and updated 
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population and baseline mortality rates. In comparison with Lim et al. (2012), we use the same 
exposure-response functions for ozone and PM2.5, but we estimate anthropogenic PM2.5 
mortality, while Lim et al. (2012) estimated total PM2.5 mortality and considered a low-
concentration threshold for ozone mortality and baseline mortality rates for COPD only (while 
we considered all Chronic Respiratory diseases); differences in the spatial distributions of 
pollutant concentrations and exposed population may also be important. The other studies were 
based on model output from different global models using different inputs and definitions of 
anthropogenic air pollution (Fang et al., 2013; Lelieveld et al., 2013) or were based on 
observations and model output of total pollutant concentrations (Evans et al., 2013); their health 
impact assessments used the log-linear exposure-response function for PM2.5, and different 
population and baseline mortality rates.  
Our estimates of almost 50,000 PM2.5 -related deaths/year due to Shipping & Aviation are 
about 30% lower than the combined estimates of Corbett et al. (2007) for Shipping and Barrett et 
al. (2010) for Aviation, but within their confidence intervals. For Land Transportation, our 
estimate is 12% lower than that of Chambliss et al. (2014), reflecting a different methodology 
despite using identical modeled PM2.5 concentrations. 
We choose not to add ozone and PM2.5 mortality to avoid possibly double counting 
respiratory mortality (since we include PM2.5 mortality associated with COPD). However, we 
calculated ozone respiratory mortality using RR from Jerrett et al. (2009), who controlled for 
PM2.5, so double counting should be negligible due to different biological mechanisms associated 
with exposure to each pollutant (Anenberg et al., 2010). Our results are  limited by applying the 
same RRs worldwide, even though underlying health conditions and PM2.5 composition vary. 
The RR for ozone is based on results from a US cohort (Jerrett et al., 2009), while the IER 
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function for PM2.5 is based on studies in North America, Western Europe and China (Burnett et 
al., 2014). Also, we limit our study to adults aged 25 and over, which may underestimate total 
and sectoral burdens. Our results are also limited by resolution and cannot fully resolve fine 
concentration gradients, particularly near urban areas.  For example, emissions from the 
Residential & Commercial sector occur where people live, and more detailed spatial analyses 
may suggest a greater relative impact for this sector. Our uncertainty estimates are wider than 
other studies, reflecting our use of the spread of modeled concentrations from the ACCMIP 
multi-model ensemble.  These estimates of uncertainty do not account for uncertainty in 
emissions inventories (as the ensemble used identical emissions), nor for uncertainty in 




We find regional differences in the relative importance of emissions sectors to ambient 
air pollution-related mortality. Globally, we estimate 493,000 deaths/year due to anthropogenic 
ozone and 2.2 million deaths/year due to anthropogenic PM2.5. Land Transportation has the 
greatest impact on ozone respiratory mortality (80,900 deaths/year, 16% of the global burden), 
while the Residential & Commercial sector contributes the most to PM2.5 -related premature 
mortality (IHD+Stroke+COPD+LC) (675,000 deaths/year, 30%). 
In East Asia, Industry has the greatest impact on ozone mortality (14%), and also has a 
great impact on PM2.5 mortality (17%) following Residential & Commercial (21%). In India, 
Energy has the greatest impact on ozone mortality (17%), but the Residential & Commercial 
sector clearly dominates PM2.5 mortality (43%). In North America, Land Transportation has the 
greatest impact both for ozone (23%) and PM2.5 mortality (55%). 
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Uncertainty in RR and in modeled ozone concentrations have similar contributions to 
overall uncertainty in ozone mortality, while uncertainty in  in the RR model parameters alpha, 
gamma and delta together has the greatest impact on total PM2.5 mortality and, especially, on 
COPD and LC mortality. Future epidemiological research on the long-term effects of air 
pollution should aim to narrow the uncertainty in RR, particularly in developing nations 
worldwide. Future research should also focus on improving emissions inventories for air quality 
modeling and reducing the bias in modeled air pollutant concentrations.  
The relative impact of removing emissions from different sectors to anthropogenic ozone 
and PM2.5-related mortality in different regions suggests that location-specific air pollution 
control policies are appropriate. However, some emission control strategies may be pursued 
globally, such as the development of improved emission control technologies.  Global actions to 
reduce emissions of ozone precursors from Land Transportation would be particularly beneficial 
for health, as would reducing PM2.5 emissions from the Residential & Commercial sector. In East 
Asia, additional air pollution control strategies addressing all sectors would considerably lessen 
global mortality. A focus on the Energy sector and PM2.5 emissions from Industry in India, and 
PM2.5 emissions from Land Transportation in North America and Europe would yield the 







4.6 Tables and Figures 
 
Table 4.1 – Premature ozone and PM2.5-related global mortality, and impact of removing emissions from individual sectors (deaths in 
2005), showing the mean and 95% CI from 1000 Monte Carlo simulations. All numbers are rounded to three significant digits. 






Ozone 493,000 115,000 80,900 65,200 45,600 53,700 
mortality (122,000-989,000) (27,800-244,000) (17,400-180,000) (14,500-143,000) (8,700-96,800) (12,300-116,000) 
PM2.5 2,230,000 261,000 212,000 290,000 323,000 675,000 






(A) Ozone mortality 
 
(B) PM2.5 mortality 
 
 
deaths per year per 1000 km2 
Figure 4.1 – Premature ozone-related respiratory mortality (A) and PM2.5-related mortality 
(IHD+Stroke+COPD+LC) (B) in 2005 (deaths per year per 1000 km
2
), shown as the mean of 
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Figure 4.2 – Impact of removing emissions from each sector (A – E) on total ozone-related 
respiratory mortality in 2005, shown as a ratio to the total burden in each cell. Areas shown as 







Figure 4.3 – Impact of removing emissions from each sector on premature ozone-related 
respiratory mortality in each region and globally, relative to the total burden (deaths in 2005).  
Numbers above each column correspond to the total burden (all anthropogenic emissions zeroed-
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Figure 4.4 - Impact of removing emissions from each sector (A – E) on total premature PM2.5-
related mortality (IHD+Stroke+COPD+LC) in 2005, shown as the ratio of total burden in each 






Figure 4.5 – Impact of removing emissions from each sector on premature PM2.5-related 
mortality (IHD+Stroke+COPD+LC) in each region and globally, relative to the total burden 
(deaths in 2005).  Numbers above each column correspond to the total burden (all anthropogenic 







CHAPTER 5 – CONCLUSIONS 
 
As significant achievements in global public health reduce the incidence of 
communicable diseases and promote a tobacco-free environment, the adverse effect of air 
pollution on cardiopulmonary mortality and morbidity and on lung cancer becomes increasingly 
relevant. This research focuses on the impact of ambient air pollution on human health by 
quantifying the effect of exposure do anthropogenic ozone and PM2.5 on global premature 
mortality from respiratory and cardiovascular diseases and lung cancer. The three studies here 
included use modeled air pollutant concentrations reported by the ACCMIP ensemble of 14 
chemistry climate models (Chapters 2 and 3) and obtained with new simulations with the 
MOZART-4 CTM at a finer horizontal resolution (0.67°x0.5°) than previous studies (Chapter 4). 
The two multi-model projects also isolate the impact of past and future climate change on air 
pollution-related premature mortality. The third project includes simulations with zeroed-out 
emissions from specific emission sectors (All Transportation = Land Transportation + Shipping 
& Aviation, Land Transportation, Energy, Industry, and Residential & Commercial) to estimate 
the impact of removing emissions from each sector on the global burden of anthropogenic air 
pollution on mortality. These simulations use consistent input emissions from state-of-the-art 
global inventories. 
This research is novel in the use of output from an ensemble of global atmospheric 
models to quantify the burden of ambient air pollution on mortality and to quantify the impact of 
past and future climate change given its effect on air quality. The resulting mortality estimates 
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should be more robust, since they take into account the considerable spread of model results. 
Also, Chapters 2 and 3 are among the few studies to have assessed the effects of climate change 
on human health via changes in air quality, and they are the first to use a model ensemble at a 
global scale. Finally, previous global assessments do not to quantify the impact of removing 
emissions from each of several emission sectors to global premature mortality (Chapter 4).  
An additional strength of this research is that all estimates are obtained at a fine enough 
horizontal resolution to capture both global and regional effects, taking into account the spatial 
distribution of the exposed population and country-level cause-specific baseline mortality rates. 
Therefore, this research may help to prioritize air pollution control strategies and provide a 
framework for the integrated assessment of actions that address both air quality and climate 
change. 
 
5.1 Scientific findings 
 
Exposure to anthropogenic ozone and PM2.5 leads to over two million deaths per year, 
globally, and PM2.5 causes the greatest impact on present-day global premature mortality. Using 
output from the ACCMIP ensemble, we first estimated 470,000 (95% CI, 140,000 to 900,000) 
ozone-related deaths per year and 2.1 (1.3 to 3.0) million deaths per year due to exposure to 
PM2.5 (Chapter 2). Using updated exposed population and baseline mortality rates and a new 
CRF for PM2.5, we obtained comparable, albeit lower, estimates using the same ACCMIP 
ensemble concentrations for the present day relative to preindustrial: 382,000 (121,000 to 
728,400) ozone deaths per year and 1.70 (1.30 to 2.10) million PM2.5 deaths per year (Chapter 3). 
The new lower estimates correspond to a more restrictive choice of mortality outcomes (chronic 
respiratory diseases rather than all respiratory diseases, and IHD+STROKE+COPD rather than 
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all cardiopulmonary diseases), to a new definition of exposed population (adults aged 25 and 
older not adults aged 30 and older), and are obtained with the same exposure-response model for 
ozone (Jerrett et al., 2009) but with the recently published IER model (Burnett et al., 2014) for 
PM2.5 (instead of applying Krewski et al., 2009). These methodological updates are intended to 
align with the GBD2010 study (Lim et al., 2012). However, GBD2010 estimates the effect of 
total air pollution (from anthropogenic and natural sources) against a counterfactual low 
concentration, while here only anthropogenic air pollution is considered by comparing with 
simulations of 1850. Using these updated methods and output from simulations with MOZART-
4 results in higher estimates than those with the ACCMIP ensemble: 493,000 (122,000-989,000) 
anthropogenic ozone deaths per year and 2.2 (95% CI: 1.0 - 3.3) million deaths per year related 
to anthropogenic PM2.5 (Chapter 4). The MOZART-4 simulations estimate anthropogenic air 
pollution as the difference between total emissions and natural emissions, which are lower than 
1850 emissions, because anthropogenic fire ignitions had likely increased substantially since 
1750. 
The effect of present-day anthropogenic ozone air pollution is widespread across the 
world but the impact on mortality is the greatest in highly-populated and highly-polluted areas of 
India and East Asia, with these two regions accounting for over two-thirds of global ozone 
mortality (Chapters 2 and 4). Close to half of anthropogenic PM2.5 mortality occurs in East Asia, 
but other populated regions such as India, Southeast Asia, Europe and FSU also have 
considerable PM2.5 mortality (Chapters 2 and 4). In the southeast US, parts of Latin America and 
small regions elsewhere, there is a decrease in mortality in 2000 relative to 1850 likely related to 




As detailed in Chapter 4, globally, the zeroed-out sectors contribute about 57% of total 
anthropogenic ozone mortality. Land Transportation has the greatest global impact (16%) and 
the greatest relative impact (20 to 26%) in North America, South America, Europe, FSU and 
Middle East.  Energy and Residential & Commercial also have strong impacts in India, and all 
sectors have considerable impacts in East Asia. For anthropogenic PM2.5, the modeled sectors 
contribute 70% of total global mortality. The Residential & Commercial has the greatest impact 
globally (30%) and in most regions except North America, South America and Australia. Land 
Transportation dominates in North America (32% of total anthropogenic PM2.5 mortality in this 
region), and in Europe it has nearly the same burden (24%) as Residential & Commercial (27%). 
Within each region the impact of removing emissions from each sector varies reflecting the 
location of emission sources. 
Future concentrations of ozone and PM2.5 will be affected by climate change and by 
changes in emissions, which themselves will impact climate. The ACCMIP ensemble simulated 
the combined effect of emissions and climate change in 2030, 2050 and 2100, using 
anthropogenic and biomass burning emissions of GHG and air pollutants from the four RCP 
scenarios. Using future concentrations relative to 2000 and projections of future population and 
cause-specific baseline mortality rates, it is estimated that PM2.5 mortality decreases, reflecting 
the projected decrease in most air pollutant emissions, particularly in 2100: -1.93 million 
(RCP2.6), -2.39 million (RCP4.5), -1.76 million (RCP6.0) and -1.31 (-2.04 to -0.17) million 
(RCP8.5) deaths per year. Ozone mortality increases in some scenarios/periods, particularly in 
RCP8.5 in 2100 (316,000 [-187,000 to 1.38 million] deaths/year), likely driven by the large 
increase in methane emissions and by the net effect of climate change, but it decreases 
substantially for the three other RCPs (Chapter 3). These estimates reflect the reductions in 
  
93 
anthropogenic precursor emissions projected in the four RCPs, and alternative scenarios for 
emission trends in the 21
st
 century, considering less extensive implementation of air pollution 
controls, might result in much lower decreases in global premature mortality, or even in 
increases. 
The impact of changes in climate since preindustrial times is estimated to be much 
smaller than the potential impact of future climate change in the 21
st
 century. The increase in 
anthropogenic emissions since 1850 likely had a much greater influence on present-day air 
pollutant concentrations than past climate change. Past climate change is estimated to annually 
contribute 1,500 (-20 000 to 27,000) premature respiratory deaths related to ozone and 2,200 (-
350 000 to 140,000) CPD and LC deaths related to PM2.5 to the present-day global mortality 
burden of anthropogenic air pollution (Chapter 2). The large uncertainty in these estimates is 
related to a considerable disagreement among models, with some models suggesting that past 
climate change has reduced air pollution mortality. There is also considerable uncertainty 
regarding future climate change and its effect on air quality (section 5.2). Here, the impact of 
climate change on future air pollution-related mortality in 2030 and 2100 is quantified using the 
ACCMIP ensemble simulations with present-day emissions and future RCP8.5 climate relative 
to simulations with present-day emissions and climate. Reflecting the climate and air quality 
policies underlying RCP8.5, climate change is estimated to have a noticeable impact, particularly 
in 2100: 215,000 (-76,100 to 595,000) PM2.5-related deaths/year and 127,000 (-193,000 to 1.07 
million) ozone-related deaths/year (Chapter 3). The confidence interval of these estimates 
includes the disagreement among models in the sign of the contribution from climate change, 
with one out of five models for PM2.5 and 3 out of 10 models for ozone suggesting avoided 
mortality due to climate change in 2100. 
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5.2 Uncertainties and future research 
 
There are several sources of uncertainty in the results here estimated. These estimates are 
also limited by several assumptions regarding exposure-response relationships, exposed 
population and baseline mortality rates. 
 Both projects using output from the ACCMIP model ensemble (Chapters 2 and 3) show 
considerable variability in mortality estimates driven by different atmospheric models (using 
similar anthropogenic emissions), which highlights the importance of using output from a multi-
model ensemble. In fact, several factors contribute to uncertainty in air quality modeling. 
Emission inventories of past and present air pollutant concentrations are not yet accurate in many 
locations worldwide. Climate and air quality interaction and feedback mechanisms are not fully 
understood and reflected in modeled air pollutant concentrations, and global models simplify 
atmospheric physics and chemical processes to different degrees. This is particularly important 
when modeling air quality given scenarios of future emissions and climate change. For example, 
global models need to fully address climate sensitivity to biogenic emissions (e.g. isoprene, soil 
NOx and methane) and stratosphere-troposphere interactions (e.g. stratospheric influx of ozone). 
A better understanding of aerosol-cloud interactions, of the impact of climate change on 
wildfires, and of the impact of land use changes on regional climate and air pollution is also 
crucial. Future mortality estimates (Chapter 3) are also limited by the ranges of future climate 
and air pollutant concentrations given by the RCP scenarios, and by (unknown) uncertainty in 
population and baseline mortality rates projections.   
The new simulations with MOZART-4 (Chapter 4) confirm the existence of a bias in 
estimates at the coarser grid resolution usually used in global simulations versus a finer 
resolution. Further research on the magnitude and causes for this bias (effects on atmospheric 
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chemistry and on population and baseline mortality rates, patterns of urbanization, etc.) would 
lead to improvements in mortality estimates at the global level. Estimates of sectoral 
contributions are also limited by non-linearities in model response to changes in emissions. 
Besides uncertainty in air quality modeling, another major source of uncertainty is 
uncertainty in CRFs. First, estimates here reported are based on representative epidemiological 
studies, but do not account for the full range of relationships/magnitudes in exposure-response 
reported in the literature. Also, the same relative risks are applied worldwide, to air pollution due 
to emissions from different sectors, and into the future, in spite of differences in population 
vulnerability, PM2.5 composition, air pollutant mixtures, etc. Finally, exposed population is 
restricted to adults aged 25 and older, likely underestimating premature mortality for the whole 
population. 
 
5.3 Policy implications 
 
This research corroborates the substantial impact of ambient anthropogenic air pollution 
on present-day global mortality, and demonstrates the relative magnitude of this impact in ten 
world regions. Additionally, it shows that the impact on anthropogenic ozone and PM2.5-related 
mortality of reducing emissions from each of five sectors differs among world regions. Although 
improvement of emission control technologies will be globally beneficial to reduce air pollution-
related mortality, different air pollution control policies may be appropriate in different locations 
and targeting different emission sectors. For example, global actions to reduce emissions of 
ozone precursors from Land Transportation and PM2.5 emissions from the Residential & 
Commercial sector would be particularly advantageous to avoid premature mortality worldwide. 
However, global mortality would also be considerably reduced by additional air pollution control 
  
96 
strategies in East Asia involving all sectors, and by a focus on the Energy sector and PM2.5 
emissions from Industry in India, and PM2.5 emissions from Land Transportation in North 
America and Europe.  
If stringent air pollution control is enhanced in developed countries and not delayed in 
developing countries, future air pollution-related mortality may be considerably reduced relative 
to the present day. Work included here also supports action towards mitigating climate change, 
since it may have a significant contribution to future global mortality due to its adverse effect on 
air quality. Air quality and climate change policies should be integrated given the 
interdependency of air quality and climate. Additionally, this research quantifies impacts on 
human air pollution-related mortality, but other effects of air pollution (e.g. adverse effects on 
human morbidity, on crops and on ecosystems, etc.) and the costs of implementing air pollution 
control and climate change mitigation are also important for decision making and prioritizing 




APPENDIX A - GLOBAL PREMATURE MORTALITY DUE TO ANTHROPOGENIC 
OUTDOOR AIR POLLUTION AND THE CONTRIBUTION OF PAST CLIMATE 
CHANGE – SUPPLEMENTAL MATERIAL 
 
A.1 Ozone and PM2.5 surface concentrations 
 
The Atmospheric Chemistry and Climate Model Intercomparison Project (ACCMIP) 
included contributions from several modeling groups using global coupled chemistry-climate 
models (Table A.1).  As described by Lamarque et al. (2013) not all models are truly coupled 
chemistry-climate models.  OsloCTM2 and MOCAGE are chemical transport models driven by 
external meteorological fields, and UM-CAM and STOC-HadAM3 do not model the feedback of 
chemistry on climate.   
ACCMIP simulations of ozone concentrations from 14 models are shown in Table A.2, 
indicating which models reported results for present-day and preindustrial historical simulations 
(“Acchist 2000” and “Acchist 1850”, respectively) as well as for the experiment where 2000 
emissions are used together with 1850 climate (“Em2000Cl1850”).  While all models simulated 
year 2000 conditions, three models simulated preindustrial years that differed slightly from 1850: 
GEOSCCM (used 1850 emissions but 1870 sea surface temperatures), GFDL-AM3 (1860, Fang 
et al., 2013), and HadGEM2 (1860).  Since emissions and climate changed little between 1850 
and 1870, there is little effect of these differences (Lamarque et al., 2010).  The GISS-E2-R 
model differs from other models in that biomass burning emissions of BC and OA were scaled 
by 1.4.  Most models reported both hourly and monthly averages, while some only reported 
monthly averages.  We calculated the ratio of the 6-month ozone season maximum of 1-hr. daily 
maximum ozone to the simple annual average for all models that report hourly ozone, in each 
0.5° x 0.5° grid cell, and applied that ratio to the models that only report monthly ozone.  For 
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2000 and 1850 simulations, this was done using the average of 9 models that report hourly 
ozone, applying that to 5 models that only report monthly ozone.  In Table A.3, we show that the 
models that report monthly average ozone are not systematically different than those that report 
hourly ozone.  For Em2000Cl1850, ratios were calculated for 7 models and applied to 2 models.   
For PM2.5 (Table A.4), 6 models reported comprehensive results for aerosol species as 
mass mixing ratios, while 4 models also reported an estimate of PM2.5 (“mmrpm2p5”).  One of 
these models did not report results for the Em2000Cl1850 experiment.  Speciated results 
included six species (BC – Black Carbon, Dust, OA – (Primary) Organic Aerosol corrected to 
include species other than carbon, SO4, SOA – Secondary Organic Aerosol, and SS – Sea Salt), 
or eight species (also NH4 and NO3).  For these 6 models, we have estimated PM2.5 from the sum 
of reported species as  
 
PM2.5=BC + OA + SO4 + SOA + NO3 + NH4 + 0.25*SS + 0.1*Dust 
 
where OA accounts for species other than carbon.  The factors 0.25 and 0.1 are intended to 
indicate the fractions of sea salt and dust, respectively, that are in the PM2.5 size fraction.  For 
models that do not report NH4, it is estimated as 1.5 * SO4 + NO3 in molar units and converted 
to mass.  This function was modified for individual models based on the differences in how 
models reported individual species.  For models that do not report NO3, we chose to use a 
different approach for the case when we evaluate the global burden of disease (2000 minus 1850 
concentrations) versus when we evaluate the contribution of past climate change (2000 minus 
Em2000Cl1850).  For the global burden of disease we calculate the average (in each grid cell) of 
models that report NO3, and apply that to models that do not, in order to include modeled 
increases in NO3 from 1850 to 2000.  For the case of past climate change, however, applying 
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NO3 changes from one set of models to other models imposes patterns of change that are 
inconsistent with the effects of climate change.  Therefore, for the effects of past climate change, 
we do not make any attempt to represent NO3 for models that do not report it (this requires us to 
re-calculate the 2000 case for consistency in comparing with Em2000Cl1850). 
Figures A.1 through A.4 show the spatial distribution of the difference between pollutant 
concentrations from the present-day (2000) and past simulations (1850 or Em2000Cl1850).  
Additionally, in Tables A.5-A.8 we show the 2000 and 1850 average concentrations in ten world 
regions (Figure A.5) and globally, and the differences between present-day (2000) and past 
simulations (1850 or Em2000Cl1850), for pollutant concentrations weighted by exposed 
population (aged 30 and above). 
 
A.2 Health impact assessment 
 
We used ozone and PM2.5 surface concentrations regridded to 0.5°x0.5° horizontal 
resolution to estimate excess ozone- and PM2.5-related mortality (∆Mort) between the present-








where y0 = baseline mortality rate,  β = concentration-response factor, ∆X = present-day minus 
preindustrial ozone and PM2.5 concentrations, and Pop = exposed population.  β was derived 
from relative risks (RR) estimated in long-term epidemiological studies (see details in Table A.9) 




Exposed population included all adults aged 30 and above (Table A.10 and Figure A.6).  
We regridded population at approximately 1 km
2
 resolution (30" × 30") from the LandScan 2008 
High Resolution Global Population Data Set (http://www.ornl.gov/sci/landscan/index.shtml) to 
the global 0.5°x0.5° resolution used for estimating mortality.  Additionally, we used UN 
estimates of 2008 population per age-group per country (World Population Prospects, 2010 
Revision, http://esa.un.org/unpd/wpp/Excel-Data/population.htm) to calculate the fraction of 
population aged 30 and above at the country level, which we gridded to 0.5° × 0.5° resolution 
using ArcGIS10 geoprocessing tools.  We assumed that population over 30 is distributed 
identically to the total population within each nation.  
Baseline mortality rates for respiratory disease, cardiopulmonary disease and lung cancer 
(Table A.10) were estimated from WHO 2000-2008 cause-specific mortality for population 30 or 
above (http://www.who.int/healthinfo/morttables/en/index.html). Original country level data was 
then mapped onto a 0.5° × 0.5° grid using similar methods as for the fraction of population aged 
30 and above (Figure A.7). When country data was not available, regional mortality rates 





In Table A.11, we present the global burden of respiratory mortality associated with 
exposure to outdoor ozone for each model, while Table A.12 shows the global mortality impacts 
of past climate change on ozone-related respiratory mortality for 9 models. For both cases, we 
show results assuming no threshold and a 33.3 ppb low-concentration threshold. 
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In Tables A.13 and A.14 we present the global burden of cardiopulmonary and lung 
cancer mortality associated with exposure to outdoor PM2.5 assuming no threshold and a 5.8 
µg/m
3
 low-concentration threshold, for reported PM2.5 and PM2.5 estimated as a sum of species.  
Tables A.15 and A.16 show similar results for the impact of past climate change. 
Figures A.8-A.11 show mortality per million people in the population.  By normalizing 
by population, the plots indicate the combined effects of baseline mortality rates and changes in 
concentration.  Note that these plots normalize by the total population in each grid cell rather 





A.4 Tables and Figures 
 
Table A.1 – Models that reported ozone concentrations for ACCMIP, with model resolution as 
the number of grid cells in each dimension. 
Model Institution Contact 
Model 
Resolution References 




Dan Bergmann,  
Philip Cameron-
Smith 









Veronika Eyring,  
Irene Cionni, 
Mattia Righi 
128 64 90 Jöckel et al. 2006 




Vaishali Naik,  
Larry Horowitz 
144 90 48 
Donner et al. 2011, 
Naik et al. 2013 
GISS-E2-R NASA-GISS 
Drew T. Shindell 
Greg Faluvegi 
144 90 40 
Koch et al. 2006, 




















Kengo Sudo,  
Toshihiko 
Takemura 




Beatrice Josse 180 90 47 
Josse et al. 2004, 






144 96 26 






Stig Dalsoren,  
Ragnhild Skeie 
128 64 60 Skeie et al. 2011 
STOC-
HadAM3 










Guang Zeng 96 73 19 





Table A.2 – Ozone simulations (h – hourly output, m – only monthly output is reported). 
Models Acchist 1850 Acchist 2000 Em2000Cl1850 
CESM-CAM-superfast h h h 
CMAM h h - 
EMAC m m - 
GEOSCCM h h - 
GFDL-AM3 h h h 
GISS-E2-R h h h 
HadGEM2 m m m 
LMDzORINCA m m - 
MIROC-CHEM h h h 
MOCAGE h h h 
NCAR-CAM3.5 h h h 
OsloCTM2 m m - 
STOC-HadAM3 m m m 
UM-CAM h h h 
 
 
Table A.3 – Global population-weighted differences in ozone concentrations (2000-1850) for the 
14 models. Models with the symbol * reported only monthly average ozone concentrations. 
Models 
Difference in ozone 
concentrations  
(2000-1850) 
Deviation from  
multi-model mean  
(26.5 ppb) 
CESM-CAM-superfast 24.7 -1.8 
CMAM 17.4 -9.1 
EMAC* 26.7 0.2 
GEOSCCM 21.9 -4.6 
GFDL-AM3 30.6 4.1 
GISS-E2-R 33.5 7.0 
HadGEM2* 13.1 -13.4 
LMDzORINCA* 23.8 -2.7 
MIROC-CHEM 26.3 -0.2 
MOCAGE 40.7 14.2 
NCAR-CAM3.5 27.2 0.7 
OsloCTM2* 25.5 -1.0 
STOC-HadAM3* 33.9 7.4 
UM-CAM 26.3 -0.2 
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Table A.4 – Models that reported PM2.5 species, including 4 models that reported a metric of 















BC + OA + SOA + SO4 
(as ammonium sulfate) +  
Dust (part) + SS (part) 
8 √ √ √ 
GISS-E2-R 
BC + OA + SOA + SO4 + 
NO3 + Dust (part) + SS 
(part) 
8 √ √ √ 
HadGEM2 - 6 √ √ √ 
MIROC-CHEM 
BC + OA + SOA + SO4 
(as ammonium sulfate) +  
Dust (part) + SS (part) 
6 √ √ √ 
NCAR-CAM3.5 
BC + OA + SOA + SO4 +  
Dust (part) + SS (part) 
6 √ √ √ 
OsloCTM2 - 8 √ √ - 
(*) Function used by different models to estimate PM2.5 from model output species. For Dust and 








Table A.5 – 1850 regional and global population-weighted pollutant concentrations for the multi-
model average and the minimum and maximum among models.  Ozone is the 6-month ozone 









Estimated PM2.5  




Mean Min. Max. Mean Min. Max. Mean Min. Max. 
North 
America 
27.4 23.4 31.4 7.4 4.7 11.3 6.9 5.8 9.1 
South 
America 
23.6 18.1 30.0 5.5 2.7 10.5 4.4 2.9 8.4 
Europe 27.4 21.3 35.1 6.4 3.8 8.0 5.7 4.6 7.4 
Former 
Soviet Union 
27.3 20.3 33.0 7.7 3.2 13.2 4.5 2.9 5.3 
Africa 31.1 19.4 42.6 26.9 8.2 50.0 12.4 4.6 26.2 
India 33.2 25.5 42.8 14.3 6.0 26.6 10.9 5.6 27.6 
East Asia 27.0 21.8 31.4 9.9 4.8 19.8 5.4 4.0 6.9 
Southeast 
Asia 
20.0 14.8 24.0 4.1 1.7 5.8 4.0 2.1 9.3 
Australia 23.1 18.5 28.7 4.9 1.0 9.9 4.6 2.2 10.8 
Middle East 31.4 24.0 36.7 21.8 7.6 41.9 9.4 2.5 16.3 






Table A.6 – 2000 regional and global population-weighted pollutant concentrations for the multi-
model average and the minimum and maximum among models.  Ozone is the 6-month ozone 








Estimated PM2.5  




Mean Min. Max. Mean Min. Max. Mean Min. Max. 
North 
America 
56.1 35.7 71.8 9.6 6.0 14.6 9.8 7.2 12.5 
South 
America 
33.4 28.8 39.5 7.2 4.1 12.7 6.3 4.5 9.9 
Europe 52.4 34.2 65.2 10.0 7.6 12.6 10.9 8.8 12.2 
Former 
Soviet Union 
50.0 35.4 61.0 11.6 7.2 16.8 9.7 6.7 11.9 
Africa 45.5 36.5 58.1 31.3 12.9 51.7 16.7 8.2 30.1 
India 61.9 51.8 81.1 22.0 14.1 29.8 20.2 14.7 32.7 
East Asia 59.8 34.1 82.6 23.0 15.0 32.6 22.0 18.5 25.6 
Southeast 
Asia 
43.9 34.6 59.6 12.5 8.2 14.5 13.3 10.0 16.0 
Australia 33.1 28.1 40.1 6.3 2.1 10.9 6.1 3.5 12.2 
Middle East 61.4 51.4 73.7 26.8 13.2 45.2 15.7 7.9 22.8 







Table A.7 – Changes in regional and global population-weighted pollutant concentrations (2000-
1850) for the multi-model average and the minimum and maximum among models.  Ozone is the 








Estimated PM2.5  




Mean Min. Max. Mean Min. Max. Mean Min. Max. 
North 
America 
28.7 10.7 44.8 2.2 1.2 3.3 2.9 1.2 5.0 
South 
America 
9.8 7.6 13.4 1.7 1.2 2.2 1.9 1.4 2.8 
Europe 25.0 9.9 35.1 3.6 2.5 4.7 5.2 3.5 6.8 
Former 
Soviet Union 
22.7 10.7 31.5 4.0 3.5 4.7 5.2 3.7 6.9 
Africa 14.4 11.8 17.1 4.3 1.8 6.2 4.4 3.6 5.2 
India 28.7 18.3 53.3 7.6 3.2 12.0 9.3 5.2 12.9 
East Asia 32.8 9.5 52.5 13.1 9.7 15.5 16.6 14.2 20.2 
Southeast 
Asia 
23.9 14.4 37.7 8.4 6.5 10.1 9.2 6.7 11.4 
Australia 10.0 5.7 15.0 1.3 1.0 2.1 1.5 1.1 2.9 
Middle East 30.0 19.5 40.9 5.1 3.3 5.8 6.3 5.4 7.0 






Table A.8 – Changes in regional and global population-weighted differences in pollutant 
concentrations due to past climate change (2000-Em2000Cl1850) for the multi-model average 
and the minimum and maximum among models.  Ozone is the 6-month ozone season average of 
1-hr. daily maximum ozone, and PM2.5 is the annual average.  Because a smaller set of models is 
used in the climate change experiment, the average 2000 concentrations (from which these are 








Estimated PM2.5  




Mean Min. Max. Mean Min. Max. Mean Min. Max. 
North 
America 
0.46 -0.78 1.67 0.23 -0.10 0.70 0.21 -0.31 0.96 
South 
America 
-0.25 -0.83 0.31 0.08 -0.23 0.22 0.10 0.06 0.20 
Europe -0.33 -0.91 0.58 0.08 -0.63 0.48 0.01 -0.92 0.35 
Former 
Soviet Union 
-0.15 -1.34 1.02 0.05 -1.36 0.96 0.07 -0.74 0.34 
Africa -0.73 -2.67 0.24 0.06 -4.86 3.17 -0.21 -2.27 0.97 
India 0.20 -2.42 2.50 -0.13 -2.38 2.57 -0.50 -4.89 1.30 
East Asia 0.19 -0.89 1.73 0.77 -1.08 2.00 0.34 -0.44 1.59 
Southeast 
Asia 
0.23 -0.63 1.39 0.40 0.09 0.57 0.16 -0.38 0.43 
Australia -0.28 -1.52 0.57 0.16 0.05 0.27 0.24 0.05 0.66 
Middle East -0.21 -1.43 0.38 -0.23 -2.06 1.81 0.11 -0.37 0.81 
GLOBAL 0.02 -0.71 0.83 0.25 -0.04 0.52 0.04 -0.97 0.41 
 
 
Table A.9 – Relative risk (central estimate and 95% CI) of death attributable to a change in 
pollutant concentrations. 
Cause of Death (ICD-9 classification) 
Ozone, 10 ppb 
increase 




Cardiopulmonary disease (B26-29, B300, 
B31-32) 
- 1.128 (1.077–1.182) b 
Respiratory diseases (B31-32) 1.040 (1.013-1.067) 
a
 - 




Jerrett et al. (2009)  - Two-pollutant model controlling for PM2.5, population ≥30 years old. 
b
 Krewski et al. (2009) – Random Effects Cox Model, adjusted for 44 individual-level and seven 





Table A.10 – Regional and global population (for age 30 and older) and average cause-specific 
mortality rates (also for age 30 and older) (deaths per year per 1000 people). 
 








North America 283 4.673 0.654 1.127 
South America 182 4.143 0.235 1.091 
Europe 343 6.239 0.736 1.064 
Former Soviet Union 161 12.252 0.489 0.785 
Africa 237 6.338 0.083 1.346 
India 555 6.768 0.147 2.006 
East Asia 881 5.971 0.620 1.930 
Southeast Asia 280 5.222 0.334 1.347 
Australia 16 4.000 0.525 0.797 
Middle East 239 5.062 0.143 0.621 
Total 3176 7.882 0.544 1.897 
 
 
Table A.11 – Global burden of ozone-related respiratory mortality for all 14 models used 
(thousand deaths per year).  
Models 
Global Mortality  
no threshold  
Global Mortality  
with 33.3ppb 
threshold  
CESM-CAM-superfast 436 308 
CMAM 313 203 
EMAC 478 395 
GEOSCCM 387 328 
GFDL-AM3 545 492 
GISS-E2-R 591 481 
HadGEM2 230 145 
LMDzORINCA 428 383 
MIROC-CHEM 467 331 
MOCAGE 720 633 
NCAR-CAM3.5 477 346 
OsloCTM2 458 294 
STOC-HadAM3 602 523 




Table A.12 – Impact of past climate change on ozone-related respiratory mortality for 9 models 
(thousand deaths per year).   
Models 
Total Mortality,  
no threshold 
Total Mortality,  
with 33.3ppb 
threshold 
CESM-CAM-superfast -9 -8 
GFDL-AM3 9 9 
GISS-E2-R 21 22 
HadGEM2 -16 -16 
MIROC-CHEM 0 0 
MOCAGE 7 7 
NCAR-CAM3.5 1 2 
STOC-HadAM3 4 4 
UM-CAM -4 -3 
 
Table A.13 – Global burden of PM2.5-related cardiopulmonary mortality (thousand deaths per 
year). 
Models 










(sum of species) 
GFDL-AM3 1,873 2,095 1,678 1,918 
GISS-E2-R 1,580 2,107 1,527 1,934 
HadGEM2 - 1,723 - 1,617 
MIROC-CHEM 1,416 1,837 1,075 1,503 
NCAR-CAM3.5 1,508 2,198 1,481 2,013 
OsloCTM2 - 1,775 - 1,435 
 
 
Table A.14 – Global burden of PM2.5-related lung cancer mortality (thousand deaths per year). 
Models 











(sum of species) 
GFDL-AM3 138 157 122 143 
GISS-E2-R 136 179 132 164 
HadGEM2 - 152 - 142 
MIROC-CHEM 104 144 76 118 
NCAR-CAM3.5 125 178 123 162 




Table A.15 – Impact of past climate change on PM2.5-related cardiopulmonary mortality 
(thousand deaths per year). 
Models 













GFDL-AM3 105 105 103 103 
GISS-E2-R -21 70 -21 70 
HadGEM2  - -279 - -283 
MIROC-CHEM 119 65 113 61 
NCAR-CAM3.5 -24 36 -25 36 
 
 
Table A.16 – Impact of past climate change on PM2.5-related lung cancer mortality (thousand 
deaths per year). 
Models 













GFDL-AM3 6.4 6.2 6.2 6.1 
GISS-E2-R 5.7 6.8 5.7 6.8 
HadGEM2  - -4.5 - -5.0 
MIROC-CHEM -2.0 0.3 -2.5 0.0 









Figure A.1 – Multi-model mean change in ozone concentration (2000-1850) for 14 models (ppb), 




Figure A.2 – Multi-model mean change in ozone concentration due to past climate change 
(2000-Em2000Cl1850) for 9 models (ppb), for the 6-month ozone season average of daily 




Figure A.3 – Multi-model mean annual average change in PM2.5 concentration (2000-1850) for 6 
models (µg m
-3
), with PM2.5 estimated as the sum of species. 
 
 
Figure A.4 – Multi-model mean annual average change in PM2.5 concentration due to past 
climate change (2000-Em2000Cl1850) for 5 models (µg m
-3
), with PM2.5 estimated as the sum of 
species. 
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Figure A.7 – Baseline mortality rates by cause for population aged 30 and above (deaths per year 




Figure A.8 – Anthropogenic burden (2000-1850) on mortality related to ozone per million people 
in total present-day population for the multi-model average (deaths per year per million people).   
 
 
Figure A.9 – Anthropogenic burden (2000-1850) on mortality related to PM2.5 per million people 
in total present-day population for the multi-model average where PM2.5 is calculated as a sum of 




Figure A.10 – Effect of past climate change (2000-Em2000Cl1850) on mortality related to ozone 
per million people in the total present-day population for the multi-model average (deaths per 




Figure A.11 – Effect of past climate change (2000- Em2000Cl1850) on mortality related to 
PM2.5 per million people in the total present-day population for the multi-model average where 




APPENDIX B - THE EFFECT OF FUTURE AMBIENT AIR POLLUTION ON  
HUMAN HEALTH AND THE CONTRIBUTION OF CLIMATE CHANGE 
 – SUPPLEMENTAL MATERIAL 
  
B.1 Air pollutant ambient concentrations 
 
The Atmospheric Chemistry and Climate Model Intercomparison Project (ACCMIP) 
included contributions from several modeling groups. While up to 14 models reported ozone 
concentrations, only up to 6 models reported species used in the calculation of PM2.5 
concentrations, and up to 4 models reported their own estimate of PM2.5 concentrations (Table 
B.1). 
Figure B.1 shows ten world regions used for all regional calculations presented below. 
Global population-weighted differences (Future year – 2000) in ozone and PM2.5 
concentrations for the different models are shown in Tables B.2 and B.3, respectively, while 
regional multi-model average differences are shown in Figures B.2 and B.3. For both pollutants, 
metrics are consistent with the underlying epidemiological studies for the health impact 
assessment: 
 Seasonal (6-month) average of daily 1-hr maximum ozone concentration; 
 Annual average PM2.5 concentration. 
PM2.5 concentration is estimated using the sum of PM2.5 species mass mixing ratios 
reported by six models: 
Estimated PM2.5=BC + OA + SO4 + SOA + NO3 + NH4 + 0.25*SS + 0.1*Dust, 
where BC – Black Carbon, Dust, OA – (Primary) Organic Aerosol corrected to include 
species other than carbon, SO4, SOA – Secondary Organic Aerosol, and SS – Sea Salt, following 
  
119 
Fiore et al. (2012) and Silva et al. (2013). The factors 0.25 and 0.1 are intended to indicate the 
fractions of sea salt and dust that are in the PM2.5 size fraction. 
The impact of climate change on global population-weighted differences 
(Em2000Cl2030/2100 minus acchist2000) in ozone and PM2.5 concentrations for the different 
models are shown in Tables B.4 and B.5, respectively, while regional multi-model average 
differences are shown in Figures B.4 and B.5. 
 
B.2 Future Population and Baseline Mortality Rates 
 
Figure B.6 shows future total and exposed population in 2030, 2050 and 2100 estimated 
from IFs country-level population per age group, used in the health impact assessment, as well as 
UN and RCP totals as context. 
Figure B.7 shows baseline mortality rates for chronic Respiratory diseases (RESP), 
ischemic heart disease (IHD), cerebrovascular disease (STROKE), chronic obstructive 
pulmonary disease (COPD) and lung cancer (LC) estimated from IFs country-level mortality 
rates of cardiovascular diseases, chronic respiratory diseases and malignant neoplasms. Here we 
show average values for the exposed population (adults age 25 and older), but we used age 
distributed values for IHD and STROKE in the premature mortality calculation to align with 









B.3 Detailed results 
 
B.3.1 Future premature mortality (due to emissions and climate change) 
 
Table B.6 shows the multi-model average global future ozone premature mortality, 
including uncertainty, while Table B.7 shows the multi-model average across ten world regions. 
Table B.8 shows the multi-model average global PM2.5 mortality (IHD+STROKE+COPD+LC, 
including uncertainty, while Table B.9 shows the multi-model average across ten world regions.  
Tables B.10 and B.11 show the global burden on mortality of ozone and PM2.5 
concentrations in 2000 relative to 1850, using present-day population and baseline mortality 
rates, and in 2030, 2050 and 2100 for all RCPs relative to 1850, using future population and 
baseline mortality rates. Also shown are two alternative cases for global burden calculation, 
using: A) 2000 concentrations relative to 1850 and present-day population but future baseline 
mortality rates; B) 2000 concentrations relative to 1850 but future population and baseline 
mortality rates.  
 
B.3.2 Impact of climate change 
 
Tables B.12 and B.13 show the multi-model averages of the impact of climate change on 








B.4 Tables and Figures 
Table B.1 – Models that reported ozone, PM2.5 species and PM2.5 (mmrpm2p5) concentrations for ACCMIP, with type of ozone output 
(h – hourly, m – monthly) and number of reported PM2.5 species. 




Dan Bergmann,  
Philip Cameron-Smith  
h - Lamarque et al., 2012  
CMAM  CCCMA, Environment Canada  David Plummer  h - Scinocca et al., 2008  
EMAC  DLR, Germany  
Veronika Eyring,  
Irene Cionni,  
Mattia Righi  
m - Jöckel et al., 2006  
GEOSCCM  NASA GSFC  Sarah Strode  h - Oman et al., 2011  
GFDL-AM3  NOAA GFDL  
Vaishali Naik,  




Donner et al., 2011;  
Naik et al., 2013  
GISS-E2-R  NASA-GISS  
Drew T. Shindell  




Koch et al., 2006;  
Shindell et al., 2013b  
HadGEM2  
Hadley Centre Met 
Office, UK  
William Collins,  
Gerd Folbert,  
Steven Rumbold  
m 6 Collins et al., 2011  





Kengo Sudo,  








Beatrice Josse  
h - 
Josse et al., 2004;  
Teyssedre et al., 2007  
NCAR-CAM3.5  NCAR  




Lamarque et al., 2011,  
2012  
OsloCTM2  CICERO and Univ. Oslo, Norway  
Stig Dalsoren,  
Ragnhild Skeie  
m 8 Skeie et al., 2011  
STOC-HadAM3  
University of  
Edinburgh, UK  
Ian MacKenzie,  
Ruth Doherty,  




Stevenson et al., 2004  






Table B.2  – Global population-weighted differences (Future year – Hist. 2000) in ozone concentrations (ppb) for the 14 models in 
2030, 2050, 2100 for the four RCPs. Pollutant concentrations are weighted by exposed population (adults aged 25 and older) in each 
future year. Models with the symbol * reported only monthly average ozone concentrations.  
Models 
2030 2050 2100 
RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
CESM-CAM-
superfast 
   
3.7 
       
9.7 
CMAM -1.2 2.1 
 
4.4 





          
-4.7 
 GFDL-AM3 0.5 4.7 1.3 9.0 -1.3 1.6 2.3 5.7 -8.7 -9.6 -8.3 5.1 
GISS-E2-R 0.2 4.2 1.5 12.0 0.1 0.2 2.9 5.6 -5.1 -11.7 -7.6 2.9 
MIROC-CHEM -0.5 
 
0.9 6.9 -2.3 
 










NCAR-CAM3.5 -2.5 0.9 -2.1 3.7 
    
-11.7 -11.2 -11.4 0.9 
UM-CAM -1.4 2.5 
 
7.1 




CICERO-OsloCTM2 0.0 2.8 
 
8.2 













HadGEM2 -0.9 -0.1 
 
0.5 
























Table B.3  – Global population-weighted differences (Future year – Hist. 2000) in PM2.5 concentrations (estimated as a sum of 
reported species) (µg/m
3
) for the 6 models in 2030,2050, 2100 for the four RCPs. Pollutant concentrations are weighted by exposed 
population (adults aged 25 and older) in each future year.  
Models 
2030 2050 2100 
RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 RCP2.6 RCP4.5 RCP6.0 RCP8.5 
GFDL-AM3 0.1 1.1 0.03 1.9 -3.4 -2.3 1.4 -1.0 -5.6 -6.3 -4.8 -3.3 
GISS-E2-R -2.0 -1.3 0.9 0.1 -4.4 -4.5 0.8 -3.1 -5.1 -5.9 -5.1 -4.0 
NCAR-CAM3.5 -0.4 0.01 -0.03 1.3 
    
-5.7 -6.4 -4.9 -3.9 
MIROC-CHEM 0.2 
 
0.5 1.0 -2.7 
 










HadGEM2 0.5 0.9 
 
1.7 







Table B.4 – Impact of climate change on global population-weighted differences 
(Em2000Cl2030/2100 minus acchist2000) in ozone concentrations (ppb) for the 10 models. 
Pollutant concentrations are weighted by exposed population (adults aged 25 and older) in each 
future year. Models with the symbol * reported only monthly average ozone concentrations.  
Models 2030 2100 
CESM-CAM-superfast -0.2 -1.6 
GFDL-AM3 0.3 -0.3 
GISS-E2-R -0.6 0.9 
MIROC-CHEM 0.3 0.4 
MOCAGE 0.2 0.6 
CAM3.5 0.1 -0.8 
UM-CAM -0.6 -1.6 
EMAC 2.6 10.3 
HadGEM2  1.5 
STOC-HadAM3 1.2 1.6 
 
 
Table B.5 – Impact of climate change on global population-weighted differences 
(Em2000Cl2030/2100 minus acchist2000) in PM2.5 concentrations (estimated as a sum of 
reported species) (µg/m
3
) for the 5 models. Pollutant concentrations are weighted by exposed 
population (adults aged 25 and older) in each future year.  
Models 2030 2100 
GFDL-AM3 0.6 1.3 
GISS-E2-R -0.1 -0.2 
NCAR-CAM3.5 0.03 0.5 
MIROC-CHEM 0.3 1.5 





Table B.6 – Global respiratory premature ozone mortality in 2030, 2050 and 2100 for the RCPs 
relative to 2000 concentrations, showing multi-model average (deaths/year) with 95% CI in 
parenthesis including uncertainty in the RRs and across models. These results are included in 
Figure 3.1. All numbers are rounded to three significant digits. 
 
2030 
RCP2.6 11,600 (-61,700 , 143,000) 
RCP4.5 99,000 (-15,300 , 236,000) 
RCP6 70,200 (-37,700 , 170,000) 
RCP8.5 264,000 (-39,300 , 648,000) 
 
2050 
RCP2.6 -449,000 (-1,360,000 , -103,000) 
RCP4.5 -361,000 (-976,000 , -50,300) 
RCP6 434,000 (21,500 , 998,346) 
RCP8.5 246,000 (59,600 , 556,000) 
 
2100 
RCP2.6 -1,020,000 (-1,930,000 , -334,000) 
RCP4.5 -913,000 (-1,830,000 , -212,000) 
RCP6 -715,000 (-1,440,000 , -189,000) 
RCP8.5 316,000 (-187,000 , 1,380,000) 
 
 
Table B.7 – Premature ozone-related respiratory mortality in ten world regions relative to 2000 
concentrations: (a) 2030, (b) 2050, (c) 2100, showing the multi-model average (deaths/year) of 
the deterministic results. All numbers are rounded to three significant digits. 
 
(a) 2030 
Region RCP2.6 RCP4.5 RCP6.0 RCP8.5 
North America -17,000 -12,500 -10,900 -8,200 
South America -2,710 -500 -3,260 1,840 
Europe -8,870 -5,590 -7,190 -880 
Former Soviet Union -2,200 -1,030 -1,600 660 
Africa 2,100 6,440 -3,520 9,020 
India 52,900 82,000 -6,440 124,000 
East Asia -11,300 25,700 103,000 127,000 
Southeast Asia 2,980 5,010 4,890 5,980 
Australia -280 -120 -100 20 
Middle East -3,630 930 -3,700 7,460 







Region RCP2.6 RCP4.5 RCP6.0 RCP8.5 
North America -85,500 -70,200 -52,100 -41,100 
South America -8,180 -4,910 -8,920 8,530 
Europe -49,400 -40,000 -34,800 -16,600 
Former Soviet Union -9,760 -6,390 -5,710 -440 
Africa 13,100 16,600 -5,520 30,500 
India 154,000 290,000 32,200 256,000 
East Asia -439,000 -514,000 518,000 3,830 
Southeast Asia 900 -21,300 19,600 -9,920 
Australia -1,260 -590 -490 250 
Middle East -24,800 -9,930 -21,100 18,300 




Region RCP2.6 RCP4.5 RCP6.0 RCP8.5 
North America -104,000 -66,300 -111,000 -21,100 
South America -19,800 -20,200 -25,900 7,950 
Europe -44,600 -24,900 -41,600 2,390 
Former Soviet Union -12,500 -8,180 -11,100 1,290 
Africa 51,100 -16,000 -49,400 128,000 
India -230,000 -267,000 -125,000 292,000 
East Asia -509,000 -383,000 -241,000 -99,700 
Southeast Asia -65,000 -71,400 -28,000 -21,000 
Australia -1,620 -990 -1,510 790 
Middle East -83,400 -58,100 -83,200 29,800 




Table B.8 – Global premature PM2.5 mortality (IHD+Stroke+COPD+LC) in 2030, 2050 and 2100 
for the RCPs relative to 2000 concentrations, showing multi-model average (deaths/year) with 
95% CI in parenthesis including uncertainty in the RRs and across models. These results are 
included in Figure 3.4. All numbers are rounded to three significant digits. 
 
2030 
RCP2.6 -258,000    
RCP4.5 -289,000    
RCP6 -169,000    
RCP8.5 17,200 (-386,000 , 661,000) 
 
2050 
RCP2.6 -1,670,000    
RCP4.5 -1,760,000    
RCP6 16,700    
RCP8.5 -1,210,000 (-1,730,000 , -835,000) 
 
2100 
RCP2.6 -1,930,000    
RCP4.5 -2,390,000    
RCP6 -1,760,000    
RCP8.5 -1,310,000 (-2,040,000 , -174,000) 
 
 
Table B.9 – Premature PM2.5 mortality (IHD+Stroke+COPD+LC) in ten world regions: (a) 2030, 
(b) 2050, (c) 2100, showing the multi-model average (deaths/year) of the deterministic results. 
All numbers are rounded to three significant digits. 
 
(a) 2030 
Region RCP2.6 RCP4.5 RCP6.0 RCP8.5 
North America -77,800 -83,500 -59,700 -77,100 
South America -570 -6,100 -6,960 -6,290 
Europe -153,000 -152,000 -137,000 -176,000 
Former Soviet Union -119,000 -82,000 -101,000 -116,000 
Africa 35,100 31,800 -10,200 46,100 
India 150,000 176,000 -2,690 245,000 
East Asia -90,100 -137,800 151,000 86,000 
Southeast Asia 27,800 -30,700 36,200 -430 
Australia -560 -180 -440 -30 
Middle East -30,700 -4,430 -37,400 -7,230 






Region RCP2.6 RCP4.5 RCP6.0 RCP8.5 
North America -106,000 -114,000 -104,000 -107,000 
South America -7,550 -9,550 -6,720 -7,940 
Europe -198,000 -187,000 -193,000 -200,000 
Former Soviet Union -144,000 -158,000 -154,000 -156,000 
Africa 40,200 46,000 -21,100 66,100 
India -6,540 97,000 152,000 308,000 
East Asia -1,050,000 -1,200,000 356,000 -906,000 
Southeast Asia -113,000 -193,000 52,500 -182,000 
Australia -370 -390 -250 -240 
Middle East -81,200 -47,800 -64,300 -47,200 




Region RCP2.6 RCP4.5 RCP6.0 RCP8.5 
North America -105,000 -128,000 -116,000 -110,000 
South America -15,600 -21,300 -12,800 -15,000 
Europe -104,000 -110,000 -112,000 -103,000 
Former Soviet Union -75,200 -109,000 -111,000 -97,500 
Africa 111,000 -68,100 -107,000 147,000 
India -531,000 -606,000 -315,000 62,700 
East Asia -886,000 -926,000 -673,000 -882,000 
Southeast Asia -153,000 -250,000 -103,000 -202,000 
Australia 30 -850 -770 -440 
Middle East -168,000 -176,000 -209,000 -127,000 




Table B.10 – Global burden on mortality of ozone concentrations in the present-day for 2000 
concentrations relative to 1850, showing multi-model average and 95% CI including uncertainty 
in RR and across models (deaths/year), and in 2030, 2050 and 2100 for all RCPs relative to 
1850, showing multi-model averages (deaths/year) given by the deterministic values. Also 
shown, future burdens using (Case A) 2000 concentrations relative to 1850 and present-day 
population but future baseline mortality rates and (Case B) 2000 concentrations relative to 1850 
but future population and baseline mortality rates. These results are plotted in Figure 3.7. All 
numbers are rounded to three significant digits. 
 
 2000 2030 2050 2100 
Present-day 382,000  
(121,000 to 728,400) 
   
RCP2.6   756,000  1,840,000   1,170,000 
RCP4.5   775,000   1,990,000   1,090,000 
RCP6.0   891,000   2,600,000   1,570,000 
RCP8.5   972,000   2,460,000   2,360,000  
Case A   569,000   1,540,000   1,490,000  
Case B   735,000   2,090,000   2,040,000 
 
 
Table B.11 – Global burden on mortality of PM2.5 concentrations in the present-day for 2000 
concentrations relative to 1850, showing multi-model average and 95% CI including uncertainty 
in RR and across models (deaths/year), and in 2030, 2050 and 2100 for all RCPs relative to 
1850, showing multi-model averages (deaths/year) given by the deterministic values. Also 
shown, future burdens using (Case A) 2000 concentrations relative to 1850 and present-day 
population but future baseline mortality rates and (Case B) 2000 concentrations relative to 1850 
but future population and baseline mortality rates. These results are plotted in Figure 3.8. All 
numbers are rounded to three significant digits. 
 
 2000 2030 2050 2100 
Present-day 1,700,000 
(1,300,000 to 2,100,000) 
   
RCP2.6  2,360,000  1,820,000  948,000 
RCP4.5  2,440,000     1,870,000       559,000  
RCP6.0  2,640,000     3,500,000    1,350,000  
RCP8.5  2,620,000     2,250,000   1,550,000  
Case A  1,590,000  1,440,000  1,230,000 






Table B.12 – Impact of climate change on premature ozone-related respiratory mortality in ten 
world regions: 2030 and 2100, showing multi-model averages (deaths/year) of the deterministic 
results. All numbers are rounded to three significant digits. 
Region 2030 2100 
North America           1,500          13,100  
South America               360            3,030  
Europe               930            5,500  
Former Soviet Union                 70                410  
Africa               380          -5,060 
India           3,170          40,100  
East Asia           4,370         64,600  
Southeast Asia             -410           2,070  
Australia                 60                440  
Middle East               300            4,050  
Global         10,700        128,000  
 
 
Table B.13 – Impact of climate change on premature PM2.5-related mortality 
(IHD+STROKE+COPD+LC) in ten world regions: 2030 and 2100, showing multi-model 
averages (deaths/year) of the deterministic results. All numbers are rounded to three significant 
digits. 
 
Region 2030 2100 
North America 6,850 19,400 
South America 1,590 6,420 
Europe 8,090 9,800 
Former Soviet Union 7,000 11,800 
Africa -2,590 -26,000 
India 17,500 82,100 
East Asia 9,160 48,900 
Southeast Asia 2,720 15,100 
Australia 40 270 
Middle East 5,860 50,300 























Figure B.3 – Regional population-weighted difference in PM2.5 concentrations (µg/m
3
) in 2030, 2050 and 2100 relative to 2000. 
 
 134 
Figure B.4 – Impact of climate change on regional population-weighted difference in ozone 




Figure B.5 - Impact of climate change on regional population-weighted difference in PM2.5 
concentrations (µg/m
3




Figure B.6 – Present-day and future population (millions of people) showing regional and global 
totals for exposed population from Landscan 2011 (2010) and IFs (2030, 2050, 2100), as well as 
total population for the RCP scenarios for 2030 and 2100 (Van Vuuren et al., 2011a) and for UN 
Population Prospects 2012 medium fertility scenario for 2030, 2050 and 2100. 
Sources: 
 ONRL - LandScan 2011 Global Population Dataset, 
http://spruce.lib.unc.edu.libproxy.lib.unc.edu/content/gis/LandScan/. Data retrieved on 
12/05/2012. 
 Web-Based IFs - The International Futures (IFs) modeling system, version 6.54., 
www.ifs.du.edu. Data retrieved on 07/2012. 
 United Nations, Department of Economic and Social Affairs, Population Division (2013). 
World Population Prospects: The 2012 Revision. http://esa.un.org/wpp/Excel-









Figure B.7 – Global and regional average present-day and future baseline mortality rates (deaths per 1000 people per year) for RESP, 
IHD, STROKE, COPD and LC, for adults aged 25 and older from GBD 2010 (2010) and IFs (2030, 2050, 2100). The IHD and Stroke 
averages are shown for illustration only, since the mortality estimates are obtained using baseline mortality rates per 5-year age group.  
Sources: 
 Web-Based IFs - The International Futures (IFs) modeling system, version 6.54., www.ifs.du.edu. Data retrieved on 07/2012. 
 Global Burden of Disease Study (2010). Global Burden of Disease Study 2010 (GBD 2010) Results by Cause 1990-2010 -















Figure B.8 – Future ozone respiratory mortality per million people for all RCP scenarios in 2030, 2050 and 2100, showing the multi-
model regional average (deaths/year per million people) in ten world regions (Figure B.1) and globally, for future air pollutant 








Figure B.9 – Future PM2.5 mortality (IHD+STROKE+COPD+LC) per million people for all RCP scenarios in 2030, 2050 and 2100, 
showing the multi-model regional average (deaths/year per million people) in ten world regions (Figure B.1) and globally, for future 








Figure B.10 – Impact of climate change on ozone respiratory mortality per million people in 2030 and 2100,  



















Figure B.11 – Impact of climate change on PM2.5 mortality (IHD+STROKE+COPD+LC) per million people in 2030 and 2100, 






APPENDIX C - THE IMPACT OF INDIVIDUAL ANTHROPOGENIC EMISSIONS 
SECTORS ON THE GLOBAL BURDEN OF HUMAN MORTALITY DUE TO 
AMBIENT AIR POLLUTION – SUPPLEMENTAL MATERIAL 
 
C.1. Input emissions 
 
Input anthropogenic and biomass burning emissions were processed from datasets at 0.5° 
x 0.5° horizontal resolution prepared for the IPCC’s Fifth Assessment Report and obtained 
through the GEIA-ACCENT Emission Data Portal
4
, for the IPCC AR5 Representative 
Concentration Pathway 8.5 (RCP8.5) global emissions inventory (Riahi et al., 2007; Van Vuuren 
et al., 2011a) for 2005.  
Anthropogenic emissions were processed as described by Fry et al. (2013), including 
speciation of volatile organic compound (VOC) species to MOZART-4 VOC categories, adding 
monthly temporal variation to all emissions species from anthropogenic sources, and regridding 
to 0.67°x0.5° horizontal resolution. We applied 1.15 and 1.4 factors to black and organic carbon 
species, respectively, to adjust for the conversion of emissions from PM1 to PM2.5 in the Bond 
inventory (Bond et al., 2004; Cooke et al. 1999) used in the emissions dataset, following Liu et 
al. (2009), Anenberg et al. (2011) and West et al. (2013). 
The baseline 2005 simulation was run with emissions from the 10 anthropogenic and 2 











C.2 Simulation with zeroed-out anthropogenic emissions 
 
For this simulation we zeroed-out emissions from all anthropogenic sectors (i.e. Energy, 
Industry, Land Transportation, Shipping, Aviation, Residential & Commercial, Solvents, 
Agriculture, Agricultural Waste Burning, Waste). Also, we set total soil NOx emissions to a 
preindustrial value (3.6 Tg N yr
-1
, estimated by Yienger and Levy, 1995), following Horowitz 
(2006), and we fixed methane concentrations at 722 ppb (Myhre et al., 2013). 
For biomass burning emissions, we took into account that climate was likely the main 
driver of global fire activity up to the earlier 18th century. In contrast, anthropogenic influence 
plays a major role afterwards; fire ignition is the greatest contributor to the increase in global fire 
activity up to the end of the 19th century and fire suppression is responsible for a considerable 
decrease in global fire activity in the 20th century (Marlon et al., 2008; Pechony and Shindell, 
2010; Power et al., 2012 and references therein). Considering that present-day savannah fires are 
mostly ignited by humans (Andrae, 1991; Schultz et al., 2008), that conditions in closed tropical 
forests are usually not conducive to biomass burning (Krawchuk et al., 2009) and that human-
ignited fires related to tropical deforestation have greatly increased in recent decades (Mieville et 
al., 2010), we assumed natural emissions from savannah and tropical forest fires to be 10% of 
present-day emissions. We took into account that fire emissions likely increased substantially 
between 1750 and the late 1800s due to anthropogenic fire ignitions (Pechony and Shindell, 
2010; Power et al., 2012 and references therein), so a 50% assumption (Moulliot et al., 2006) 
would not be applicable.   For forest fires at extratropical latitudes (greater than 30° N and 20° 
S), we assumed natural emissions to be 90% of present-day emissions to account for the reduced 




others suggest that a lower percentage may be appropriate in the boreal Eurasian forests 
(Mollicone et al., 2006). 
 
C.3 MOZART-4 performance evaluation 
 
MOZART-4 performance was evaluated by comparing surface concentrations of ozone 
and PM2.5 species (EC, OC, SO4, NH4NO3) with 2005 surface air quality observations from the 
Clean Air Status and Trends Network (CASTNet) for the US (ozone), the European Monitoring 
and Evaluation Programme (EMEP) for Europe (ozone and PM2.5 species) and the Interagency 
Monitoring of Protected Visual Environments (IMPROVE) for remote locations in the U.S. 
(PM2.5 species).   
Figures C.1 and C.2 show comparisons of modeled surface ozone with observations from 
CASTNET and EMEP, respectively. For ozone, overall mean bias is 7.2 ppb for CASTNet and 
2.3 ppb for EMEP. Throughout the year, the model shows higher biases in the US North West 
and Florida regions and, during the Summer, the highest biases are in the Great Lakes, North 
East and South East regions (regional average bias less than 25 ppb). In Europe, bias is lower 
than in the US. 
Figures C.3 to C.6 show comparisons of modeled surface concentrations of PM2.5 species 
with observations from IMPROVE and EMEP. For PM2.5 species, the model shows good 
agreement with observations. Simulated annual average surface sulfate concentrations are mostly 
within a factor of two of observations, though with a tendency to underestimate. Simulated 
annual average ammonium nitrate concentrations are generally overestimated. EC and OC 





C.4 Ozone and PM2.5 surface concentrations 
 
All averaged concentrations mentioned in this section are population-weighted averages, 
unless otherwise stated. All regional results refer to the regions shown in Figure C.7.  
 
C.4.1 Ozone  
 
Modeled hourly ozone concentrations were processed to estimate the average 1-hr daily 
maximum concentration for the consecutive 6-month period with the highest average, in each 
grid cell. 
Ozone concentrations in the baseline simulation were 56.0 ppb globally, ranging from 
39.9 to 64.1 ppb across ten world regions, with the highest values in East Asia, India and US 
(Table C.3 and Figure C.8). When all anthropogenic emissions were zeroed-out, global 
concentrations decreased to 22.2 ppb (40% of baseline) and regional concentrations ranged from 
17.0 to 24.3 ppb, reflecting a much lower spatial variability in surface ozone (Table C.3). 
Considering the results of the simulations with the different sectors zeroed-out (Table C.3 and 
Figure C.9), All Transportation had the highest contribution to surface ozone, globally (14%) and 
across all regions, with Land Transportation accounting for close to 70% of the global 
contribution from All Transportation. Land Transportation had the greatest individual 
contribution in most regions, except Africa (Residential & Commercial) and Southeast Asia and 









Annual average PM2.5 concentrations were estimated as a sum of individual model output 
species: 
PM2.5 = CB1+CB2 + (OC1*1.3+OC2*1.7) + SO4+ NO3 + SOA +   
               + 0.2*(DUST1+DUST2+DUST3) + (SA1+SA2+SA3) 
CB1 and CB2 are black carbon species. OC1 and OC2 are primary organic carbon 
species. The 1.3 and 1.7 factors applied to OC1 and OC2 account for species other than carbon in 
organic aerosol. SO4 is sulfate (estimated as ammonium sulfate). NO3 is nitrate (estimated as 
ammonium nitrate). SOA is secondary organic aerosol. DUST1, DUST2 and DUST3 and SA1, 
SA2 and SA3 are the size fractions of dust and sea salt relevant for PM2.5 (size bins 1-3). Since 
modeled windblown dust is highly uncertain and caused PM2.5 model estimates to be 
unrealistically large in arid regions, dust was adjusted with a 0.2 factor so that global PM2.5 
surface concentrations roughly agree with those estimated by Brauer et al. (2012), as had been 
done by West et al. (2013). 
PM2.5 concentrations in the baseline simulation were 22.0 µg/m
3
 globally, ranging from 
5.0 to 34.2 µg/m
3
 regionally, with the highest values in East Asia, India and Middle East (Table 
C.4 and Figure C.10). Considering different species, global black carbon averages 1.4 µg/m
3
, 
primary organic aerosol (POA) averages 6.5µg/m
3
 and dust averages 5.8µg/m
3
, while SOA 
averages 0.1µg/m
3
 and secondary inorganic aerosol (SIA = NO3+SO4) averages 4.2µg/m
3 
(Table 
C.5 and Figure C.11). Globally, POA corresponds to the greatest fraction of total PM2.5 




account for the greatest fractions, such as sulfate in North America (31%), nitrate in Europe 
(43%) and East Asia (33%), and dust in Africa (65%) and Middle East (72%). 
When all anthropogenic emissions were zeroed-out, global concentrations decreased to 
6.6µg/m
3
 (30% of baseline) and regional concentrations ranged from 1.4 to 20.6µg/m
3
 with the 
highest value in the Middle East (Table C.4). Also, the reduction was the greatest in East Asia 
(less 91%) and the least in the Middle East (less 26%) and Africa (less 30%), due to the fraction 
of dust in these latter regions. 
Considering the results of the simulations with the different sectors zeroed-out (Table C.4 
and Figure C.12), Residential & Commercial had the highest contribution to surface PM2.5, 
globally (28%) and in several regions. Land Transportation had the greatest individual 
contribution in North America and Europe. 
 
C.5 Population and Baseline Mortality Rates 
 
Table C.6 shows the global and regional total population, exposed population (adults 
aged 25 and older), and cause-specific baseline mortality rates obtained from the gridded values 
used in the health impact assessment. 
 
C.6 Additional mortality results 
 
Tables C.7 and C.8 show present-day global and regional burdens of anthropogenic 
ozone and PM2.5-related mortality. 
Tables C.9 and C.10 show ozone- and PM2.5-related total mortality rates per sector, 




million people per year due to exposure to anthropogenic ozone, compared to 69 deaths per 
million people in North America and lower rates in all other regions (Table C.9). The greatest 
sectoral global impact is due to Land Transportation, which contributes 12 deaths per million 
people per year. 
FSU has the highest anthropogenic PM2.5-related mortality rate (714 deaths/year per 
million people), closely followed by East Asia (683 deaths/year per million people), while 
Europe and India have 457 and 268 deaths/year per million people, respectively (Table C.10). 
The greatest global sectoral impact is due to Residential & Commercial, which contributes 97 
deaths per million people per year. 
We also obtained deterministic estimates for mortality, considering the mean values 
reported for each of the variables (see Tables C.11 and C.12). For anthropogenic ozone 
mortality, the global mean from the Monte Carlo simulations is 0.1% greater than the 
deterministic estimate (492,000 deaths/year), with less than ±1% differences for most regions, 
except Middle East (2%) and Africa (5%). For anthropogenic PM2.5 mortality, there is a larger 
difference (-5%) between the global mean from the Monte Carlo simulation and the deterministic 
estimate (2.36 million deaths/year), reflecting large differences at the regional level in some 
regions (e.g. -15% in India, -4% in East Asia, -6% in Europe, 19% in North America). 
 
C.7 Sensitivity Analysis (additional information) 
 
C.7.1 Fine vs. coarse resolution  
 
Using the output from simulations at 2.5°x1.9° horizontal resolution, we estimate a 




slight negative bias of 2% relative to the deterministic estimate at finer resolution (Table C.13); 
this negative bias was greater in some regions (e.g. South America, -9%; Southeast Asia, -8%; 
Africa, -6%; Australia, -12%). For anthropogenic PM2.5 mortality, we estimate 2.7 million 
deaths/year, which corresponds to a global positive bias of 16% for the coarse resolution 
estimate, resulting from considerably different regional bias, including much larger positive 
biases in North America (52%), Europe (34%) and FSU (39%), smaller positive biases in India 
(4%), East Asia (11%) and Southeast Asia (11%), and a 15% negative bias in South America 
(Table C.13). 
 
C.7.2 Low-concentration threshold for ozone 
 
By applying a low-concentration threshold of 33.3ppb to the ozone mortality calculation, 
we estimate a 27.4% decrease in the global burden, since ozone concentrations for the simulation 
with all anthropogenic emissions zeroed-out are below the threshold, except in a few very small 
areas in Africa. The low-concentration threshold has a negligible effect on the contributions of 
each sector (less than 2%) since ozone concentrations with zeroed-out sectors are lower than the 
threshold only in a few populated areas, mostly in South America and Australia. 




C.8 Tables and Figures 
 
Table C.1 – Emissions source sectors included in the RCP8.5 global emissions inventory. 
 
Sector code Short name Definition (based on IPCC/CRF source/sink sectors) 
Anthropogenic Emissions  
Ene Energy Energy production and distribution: Public electricity and heat 
production, petroleum refining, manufacture of solid fuels and other 
energy industries. Fugitive emissions from solid fuels, oil and gas. 
Ind Industry  Industrial processes and combustion: Manufacturing industries and 
construction, inc. production of metals, chemicals, pulp /paper / print, 
food processing/beverages/tobacco, and other industries. 
tra* Land Transportation Land transport: Road transportation (cars, light duty trucks, heavy 
duty trucks and buses, motorcycles, evaporative emissions from 
vehicles), railways, and other transportation (pipeline transport, off-
road). 
shp* Shipping Maritime transport: International shipping 
aircraft* Aviation Civil Aviation 
Dom Residential & Commercial  Residential and commercial combustion** 
Slv Solvents Solvent production and use 
Agr Agriculture Agriculture (animals, rice, soil): Enteric fermentation, manure 
management, rice cultivation, soil emissions, other 
Awb Agricultural Waste Burning Agriculture (waste burning on fields): Field burning of agricultural 
residues 
Wst Waste Waste Treatment and Disposal: Solid waste disposal on land, 
wastewater handling, waste incineration 
Biomass Burning Emissions   
Lcf Forest burning  Forest fires 
Sav Grassland burning  Savanna burning, grassland fires 
* All Transportation includes these three sectors. 






Table C.2 – Global emissions per sector for six pollutants (Tg/yr) in the RCP 8.5 Global 
Emissions Inventory, 2005, and the total emissions for all 12 sectors and for the sectors modeled 
in zero-out simulations (and percentage of the modeled sectors in total emissions in parenthesis). 
 
 
CO NO NMVOC SO2 BC OC 
Ene 21.1 17.1 29.1 57.7 0.05 0.3 
Dom 261.3 6.2 38.6 8.8 2.1 8.2 
Ind 114.3 11.2 9.0 26.9 1.6 2.3 
Tra 161.8 20.5 28.5 3.4 1.2 1.3 
Wst 4.1 0.2 1.5 0.05 0.04 0.05 
Agr 0.01 1.5 0.8 - - - 
Slv 1.0 
 
22.7 - - - 
Awb 19.9 0.4 2.7 0.2 0.1 0.7 
Shp 1.3 12.3 3.1 13.0 0.1 0.1 
Aircraft - 0.8 - - 0.003 - 
Lcf 229.3 3.9 41.7 2.2 1.1 12.0 
Sav 222.3 7.5 35.1 1.6 1.5 10.9 
Total 1036 81.7 212.9 113.9 7.9 35.9 
modeled sectors (% of total) 559.8 68.1 108.4 109.9 5.2 12.2 
(ene+dom+ind+tra+shp+aircraft) (54%) (83%) (51%) (96%) (65%) (34%) 
 
 
Table C.3 – Ozone concentrations for baseline and zero-out simulations (ppb), showing the 
population- weighted average for each region of the average 1-hr daily maximum ozone for the 












NA 59.8 58.1 56.0 57.0 51.4 47.5 20.3 
SA 39.9 39.0 38.4 37.4 34.6 33.0 18.6 
Europe 53.5 52.1 51.4 51.6 47.0 42.1 20.9 
FSU 48.4 47.4 45.2 46.7 43.2 40.8 21.8 
Africa 45.9 42.0 44.7 45.3 44.0 42.4 23.4 
India 60.5 55.2 54.8 58.6 54.8 53.0 24.3 
East Asia 64.1 60.3 59.6 58.8 58.7 56.7 23.8 
SE Asia 52.1 49.5 46.0 49.7 46.6 43.8 17.0 
Australia 40.0 39.1 36.1 36.1 37.7 34.9 17.3 
ME 57.4 55.3 53.3 55.1 49.5 45.8 22.7 









Table C.4 – PM2.5 concentrations for baseline and zero-out simulations (µg/m
3
), showing the 









Transp. All Anthr. 
NA 8.5 7.6 7.1 7.5 6.4 6.2 1.4 
SA 6.7 5.9 6.4 5.0 5.7 5.6 2.0 
Europe 13.9 11.1 12.0 12.5 10.9 9.9 2.7 
FSU 12.1 8.4 10.8 11.3 11.2 11.1 3.6 
Africa 16.8 14.9 16.4 16.5 16.6 16.5 11.7 
India 28.5 16.3 24.3 25.4 26.6 26.5 8.5 
East Asia 34.2 23.3 28.3 25.3 32.0 31.5 3.1 
SE Asia 12.0 8.1 10.6 10.4 11.1 10.9 1.9 
Australia 5.0 4.7 4.6 4.6 4.7 4.6 3.1 
ME 27.8 25.7 26.1 26.5 26.1 25.8 20.6 
Global 22.0 15.7 19.4 18.7 20.4 20.1 6.6 
 
 
Table C.5 – Concentrations of seven PM2.5 species in the baseline simulation (µg/m
3
), showing 
the population- weighted average for each region of the annual average concentrations. 
 
 
BC POA Sulfate SOA Nitrate Dust Sea Salt 
NA 0.6 2.2 2.6 0.1 2.1 0.5 0.4 
SA 0.6 2.9 1.5 0.1 0.2 0.8 0.6 
Europe 0.8 2.4 2.4 0.0 5.9 1.5 0.8 
FSU 0.5 4.1 1.6 0.0 2.7 2.9 0.2 
Africa 0.5 3.9 0.9 0.1 0.2 11.0 0.3 
India 1.8 10.9 3.6 0.1 3.8 8.0 0.3 
East Asia 3.0 10.0 7.1 0.1 11.3 2.4 0.3 
SE Asia 0.8 5.9 3.4 0.2 0.5 0.7 0.5 
Australia 0.3 1.0 0.9 0.1 0.2 0.9 1.6 
ME 0.6 2.5 2.7 0.0 1.5 19.9 0.5 












Table C.6 – Regional and global total population, exposed population (adults age 25 and older), 






Mortality Rates per 100,000 
(for population 25 and over) 
 
(millions) (millions) IHD Stroke COPD LC Resp 
NA 538.7  330.5  234.0  84.6  62.2  61.5  75.4  
SA         404.1   225.7  141.8  103.9  40.9  23.0  58.5  
Europe         516.7  375.0   285.3  178.4  54.7   72.1   73.5  
FSU         293.6  196.0  684.5  362.7  42.9  49.1  52.3  
Africa         885.6  315.1  65.5  98.3   18.7  6.3  37.1  
India     1,460.2  692.3  169.9  95.1  137.8  14.2  178.2  
East Asia      1,553.2   1,036.5  119.1  207.2  104.7  62.8  117.5  
SE Asia 644.9  351.4  118.2  187.8  42.2  30.6  71.3  
Australia 28.0  18.5  215.9  97.4  49.0  54.0  62.4  
ME 621.1  297.7  190.3  120.3  29.4  21.2  51.2  
Global 6,946.3  3,838.8  186.1  157.5  76.3  40.9  97.5  
Sources:  
Population - Oak Ridge National Laboratory's Landscan 2011 Global Population Dataset (Bright et al., 2012).  









Table C.7 – Premature ozone-related respiratory mortality in ten world regions, and contributions from different sectors (deaths in 
2005), showing the mean and 95% CI from 1000 Monte Carlo simulations. All numbers are rounded to three significant digits. 
  






North 37,100 12,100 8,390 3,880 3,020 1,440 
America (8,380 – 74,800) (2,840 - 25,600) (1,790 - 18,400) (880 - 8,390) (594 – 6,360) (347 – 3,040) 
South 10,300 3,450 2,650 787 1,270 416 
America (302 - 23,600) (292 - 7,950) (212 – 6,420) (38 - 1,890) (0 - 2,990) (30 – 958) 
Europe 
32,800 12,100 6,620 2,170 2,030 1,450 
(9,000 - 64,700) (3,2030 - 24,700) (1,840 - 14,100) (610 - 4,520) (498 – 4,100) (360 – 3,000) 
F. Soviet  10,300 3,090 2,040 1,230 684 402 
Union (3,230 - 19,700) (9470 - 6,070) (645 - 4,120) (370 - 2,420) (1204 - 1,350) (120 – 790) 
Africa 
10,200 1,700 907 578 303 1,490 
(3,050 - 22,900) (494 - 3,930) (267 - 2,040) (151 - 1,310) (79 – 699) (431 - 3,280) 
India 
165,000 35,900 27,100 27,500 9,160 26,000 
(40,200 - 343,000) (8,200 – 78,500) (5,560 - 59,900) (6,380 - 60,500) (1,840 – 20,000) (5,770 – 57,300) 
East Asia 
175,000 32,600 23,500 20,900 25,200 18,500 
(34,100 - 358,000) (6,000 - 70,900) (4,320 – 53,100) (4,0670 - 46,600) (4,320 - 53,800) (3,600 - 39,600) 
Southeast  32,400 7,550 5,080 5,720 2,340 2,700 
Asia (8,000 - 66,900) (1,780 - 16,200) (980 - 11,300) (920 - 13,100) (426 – 5,300) (659 - 5,790) 
Australia 
979 232 103 180 176 38 
(136 - 2,130) (35 – 520) (15 – 241) (25 – 417) (24 – 388) (5 – 86) 
Middle 19,300 6,690 4,570 2,220 1,380 1,350 
East (6,270 - 39,300) (2,110 - 13,800) (1,420 - 9,460) (634 - 4,750) (415 - 2,940) (390 - 2,920) 
Global 



















Table C.8 – Premature PM2.5-related mortality in ten world regions (IHD+Stroke+COPD+LC), and contributions from different 
sectors (deaths in 2005), showing the mean and 95% CI from 1000 Monte Carlo simulations. All numbers are rounded to three 
significant digits. 
Region All Anthropogenic All Transportation Land Transportation Energy Industry 
Residential & 
Commercial 
North 91,100 33,600 29,200 20,700 13,200 11,800 
America (6,200 - 223,000) (5,180 – 60,600) (4,540 - 51,700) (1,290 - 40,600) (1,490 - 23,500) (1,820 - 20,400) 
South 31,000 8,190 7,600 1,990 13,100 5,800 
America (1,220 - 75,100) (1,020 – 13,900) (1,010 - 12,800) (187 - 3,760) (1,090 - 23,100) (965 - 10,100) 
Europe 
236,000 76,700 56,200 38,300 25,600 64,000 
(59,900 - 382,000) (27,500 – 112,000) (22,600 - 80,900) (21,800 - 53,500) (13,000 - 36,100) (39,300 - 88,100) 
F. Soviet  210,000 30,000 26,400 37,100 21,100 113,000 
Union (48,400 - 334,000) (15,000 – 38,300) (13,600 - 33,600) (16,100 - 47,400) (11,800 - 26,600) (41,300 - 144,000) 
Africa 
28,600 1,940 1,540 2,760 2,030 12,000 
(3,530 - 57,700) (560 – 3,170) (505 - 2,480) (752 - 4,690) (466 - 3,470) (2,250 - 23,300) 
India 
392,000 21,800 19,900 39,200 36,400 173,000 
(129,000 - 590,000) (11,700 – 31,600) (11,100 -28,800) (18,900 - 57,100) (18,900 - 52,500) (88,000 - 253,000) 
East Asia 
1,060,000 61,000 48,000 117,000 178,000 223,000 
(696,000 - 1,440,000) (44,300 – 78,800) (34,700 - 62,500) (84,500 - 156,000) (127,000 - 239,000) (158,000 - 299,000) 
Southeast  120,000 14,800 12,400 20,300 24,600 59,900 
Asia (30,900 - 215,000) (5,650 – 22,300) (4,990 - 18,000)  (8,160 - 29,700) (9,080 - 36,000) (24,200 - 90,900) 
Australia 
922 309 201 292 333 223 
(0 - 3,820) (0 – 1,020) (0 – 638) (0 – 920) (0 - 1,070) (0 – 681) 
Middle 59,700 13,000 10,700 11,600 8,310 12,700 
East (41,800 - 79,600) (9,180 – 17,600) (7,550 - 14,500) (8,160 - 15,700) (5,920 - 11,100) (9,120 - 17,500) 
Global 





(114,000 –  
292,000) 
(192,000 –  
386,000) 








Table C.9 – Premature ozone-related respiratory mortality per million people in total population 
in ten world regions, and contributions from different sectors (deaths per million people in 2005), 








Transp. Energy Industry 
Resid. & 
Comm. 
NA 69  23  16  7  6  3  
SA 26  9  7  2  3  1  
Europe 63  23  13  4  4  3  
FSU 35  11  7  4  2  1  
Africa 11  2  1  1  0  2  
India 113  25  19  19  6  18  
East 
Asia 
113  21  15  13  16  12  
SE Asia 50  12  8  9  4  4  
Australia 35  8  4  6  6  1  
ME 31  11  7  4  2  2  
Global 71  17  12  9  7  8  
 
 
Table C.10 – Premature PM2.5 -related mortality (IHD+Stroke+COPD+LC) per million people in 
total population in ten world regions, and contributions from different sectors (deaths per million 
people in 2005), showing the mean from 1000 Monte Carlo simulations. All numbers are 







Transp. Energy Industry 
Resid. & 
Comm. 
NA 169 62 54 38 25 22 
SA 77 20 19 5 33 14 
Europe 457 149 109 74 50 124 
FSU 714 102 90 126 72 384 
Africa 32 2 2 3 2 14 
India 268 15 14 27 25 118 
East 
Asia 
683 39 31 76 115 144 
SE Asia 186 23 19 31 38 93 
Australia 33 11 7 10 12 8 
ME 96 21 17 19 13 20 








Table C.11 – Premature ozone-related respiratory mortality in ten world regions, and 
contributions from different sectors (deaths in 2005), showing the deterministic mean estimates. 











NA 37,400 12,000  8,500  3,960  3,020 1,430  
SA 10,400  3,430  2,680  803  1,270  415  
Europe 32,800 12,000  6,670 2,200  2,020 1,440  
FSU 10,200 3,040  2,050  1,240  678  400  
Africa 9,670  1,600  875  566  289  1,430  
India 163,000  35,200  27,000  27,700  9,020  25,700  
East 
Asia 176,000  32,300 23,800  21,400  25,300  18,500  
SE Asia 32,200 7,400  5,080  5,790  2,310  2,680  
Australia 979  229  104  183  175  38  
ME 18,900  6,490 4,510  2,200  1,340  1,330 
Global 492,000  114,000  81,300  66,000  45,400 53,400  
 
 
Table C.12 – Premature PM2.5-related mortality (IHD+Stroke+COPD+LC) in ten world regions, 
and contributions from different sectors (deaths in 2005), showing the deterministic mean 











NA 76,300 47,300 41,800 27,900 18,500 16,600 
SA 24,800 7,980 7,500 1,930 12,500 5,390 
Europe 251,000 94,700 66,000 42,800 28,900 68,200 
FSU 222,000 32,500 28,400 40,000 22,200 124,000 
Africa 29,000 2,130 1,690 3,000 2,180 12,000 




63,200 49,700 123,000 186,000 233,000 
SE Asia 124,000 15,300 12,800 21,900 26,000 63,100 
Australia 276 195 141 189 216 165 
ME 66,200 13,800 11,400 12,100 8,930 14,700 








Table C.13 – Premature ozone and PM2.5-related mortality in ten world regions for the baseline 
simulation at 2.5°x1.9° horizontal resolution (deaths in 2005), showing the deterministic mean 






NA 36,500  116,000  
SA 9,470 21,000  
Europe 32,400 337,000  
FSU 9,930  308,000  
Africa 9,060  33,600  
India 163,000 478,000  
East 
Asia 
171,000 1,230,000  
SE Asia 29,700  134,000  
Australia 862  468  
ME 18,600  80,600  












Figure C.1 – Comparison of simulated monthly mean surface ozone concentrations (2005) with 
CASTNet monitored concentrations (2005) for eight US regions, showing modeled regional 
mean (red), CASTNET regional mean (black) and individual monitoring locations (grey). An 








Figure C.2 – Comparison of simulated monthly mean surface ozone concentrations (2005) 
with EMEP monitored concentrations (2005) for six European regions, showing modeled 
regional mean (red), EMEP regional mean (black) and individual monitoring locations 










Figure C.3 – Comparison of the simulated annual average (2005) surface SO4 concentrations (µg 
m
-3
) with annual average (2005) observations from the IMPROVE(A)  and the EMEP (B) 
surface monitoring networks for the US and Europe, respectively. The left panels show modeled 
versus observed concentrations (µg m
-3
) with the dashed 1:2 and 2:1 lines representing 











Figure C.4 – Comparison of the simulated annual average (2005) surface NH4NO3 
concentrations (µg m
-3
) with annual average (2005) observations from the IMPROVE (A) and 
the EMEP (B) surface monitoring networks for the US and Europe, respectively. The left panels 
show modeled versus observed concentrations (µg m
-3
) with the dashed 1:2 and 2:1 lines 









Figure C.5 – Comparison of the simulated annual average (2005) surface EC concentrations (µg 
m
-3
) with annual average (2005) observations from the IMPROVE surface monitoring networks, 
US. The left panels show modeled versus observed concentrations (µg m
-3
) with the dashed 1:2 







Figure C.6 – Comparison of the simulated annual average (2005) surface OC concentrations (µg 
m
-3
) with annual average (2005) observations from the IMPROVE surface monitoring networks, 
US. The left panels show modeled versus observed concentrations (µg m
-3
) with the dashed 1:2 














1 – North America 
2 – South America 
3 – Europe 
4 – Former Soviet Union 
5 – (Sub-Saharan) Africa 
6 – India 
7 – East Asia (inc. China) 
8 – SE Asia 
9 – Australia (Oceania) 
10 – Middle East  
        (and North Africa) 
 




Figure C.8 – Ozone concentrations in the baseline simulation (ppb), showing the average 1-hr 







All Anthropogenic Energy 
  
Industry Residential &Commercial 
  




Figure C.9 – Difference in ozone concentrations between the baseline and zeroed-out simulations 
(ppb), using the average 1-hr daily maximum ozone for the consecutive 6-month period with the 






Figure C.10 – PM2.5 concentrations in the baseline simulation (µg/m
3
), showing the annual 
average concentrations in each cell. 
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Figure C.12 – Difference in PM2.5 concentrations between the baseline and zeroed-out 
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